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ABSTRACT 
 
Background: Patients with cancer of the upper gastrointestinal tract are susceptible 
to malnutrition. Surgery is the only curative treatment although the procedure may 
negatively impact nutritional status. The aim of this thesis was to investigate energy 
balance, body composition and functional capacity during the first year but also 
long time after major upper gastrointestinal (MUGI) surgery in two groups of 
patient on oral nutritional therapy.  
 
Methods: Oral nutritional therapy was given according to established practice 
guidelines at our hospital. Study A involved 15 individuals with a total gastrectomy 
performed at least 5 years ago. Study B involved 41 individuals during the first 
year after MUGI surgery. Several components of energy balance were measured, 
such as energy intake (4-day food record), resting energy expenditure (indirect 
calorimetry), physical activity (activity monitor ActiReg®, and activity interview 
HPAQmodified) and total energy expenditure (TEE, doubly-labelled water DLW). 
Body composition and energy stores were measured with dual energy x-ray 
absorptiometry (DXA) from which total body skeletal muscle mass (TBSMM) 
could be calculated. Functional capacity was determined as maximal exercise 
capacity with a treadmill test.   
 
Results: Study A: On group level nutritional therapy did not increase body weight, 
energy intake or TEE. Half of the patients increased their weight and half remained 
weight stable or lost weight. Presence of disease and BMI >25 affected weight 
development negatively. Both ActiReg® and HPAQmodified underestimated TEE at 
higher levels of activity compared to DLW. Actireg® estimated changes in TEE 
over time comparable to DLW.  
Study B: Weight decreased particularly during the first month after MUGI surgery 
and was 7% lower after 12 months. Nearly 90% of the body mass loss was fat. One 
third of the patients remained weight stable and gained in fat free mass. In those 
who lost weight, 26% of the body energy content was lost 6 months after surgery 
corresponding to a mean negative energy balance of 340 kcal per day. Muscle mass 
and exercise capacity were related at all occasions and changes in muscle mass 
were related to changes in exercise capacity while energy balance did not directly 
influence the relationship. However, patients in negative energy balance, lost more 
muscle mass and reduced their exercise capacity compared with patients in energy 
balance. About one third of patients had low muscle mass before surgery. 
 
Conclusions: The greatest weight loss following MUGI surgery occurred during 
the first month and persisted throughout the first year after surgery. The weight loss 
consisted primarily of fat and seemed to be persistent as weight loss in the same 
order of magnitude was found more than 5 years after surgery. Low muscle mass 
was common. Weight development varied, and approximately 30 (study B) to 50 % 
(study A) of patients increased in weight during the intervention. Co-morbidity and 
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BMI >25 seemed to be factors of importance. Muscle mass and changes in muscle 
mass affected exercise capacity. The importance of energy balance is unclear, but 
the results suggest that weight change affects muscle development and functional 
capacity.  
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SAMMANFATTNING 
 
Bakgrund: Undernäring är vanligt hos patienter med cancer i övre mag-
tarmkanalen. Kirurgi är den enda botande behandlingen även om ingreppet kan 
inverka negativt på nutritionsstatus. Syftet med detta avhandlingsarbete var att 
studera energibalans, kroppssammansättning och funktionsförmåga under det första 
året, men även lång tid efter stor övre gastrointestinal kirurgi i två grupper av 
patienter med oral nutritionsbehandling. 
 
Metoder: Oral nutritionsbehandling bedrevs enligt etablerad praxis på vårt sjukhus. 
Studie A omfattade 15 individer som genomgått total gastrektomi för minst 5 år 
sedan. Studie B omfattade 41 individer under det första året efter kirurgi. De 
komponenter i energibalansen som studerades var energiintag (4-dagars 
matdagbok), energiomsättning i vila (indirekt kalorimetri), fysisk aktivitet 
(aktivitetsmätaren ActiReg® och aktivitetsintervjun HPAQmodified) och den totala 
energiförbrukningen (TEE, dubbelmärkt vatten DLW). Kroppens sammansättning 
och energiförråd mättes med dual energy X-ray absorptiometry (DXA) varifrån 
skelettmuskulmassa beräknades. Funktionsförmåga mättes som maximal 
arbetskapacitet med ett test på gångmatta. 
 
Resultat: Studie A: Oral nutritionsbehandling ökade inte kroppsvikt, energiintag 
eller TEE på gruppnivå men hälften av patienterna ökade sin vikt och hälften 
förblev vikt stabila eller förlorade vikt. Förekomst av sjukdom och BMI> 25 
försämrade viktutveckling. Både ActiReg® och HPAQmodified underskattade TEE på 
högre aktivitetsnivåer jämfört med DLW. Actireg® beräknade förändringar i TEE 
över tiden jämförbart med DLW. 
Studie B: Viktsförlusten skedde framför allt den första månaden efter kirurgi, och 
efter 12 månader hade kroppsvikten reducerats med 7%. Nästan 90% av 
viktsförlusten bestod av fett. En tredjedel av patienterna förblev viktstabila och 
ökade i både fettfrimassa och muskelmassa. Bland de som gått ner i vikt hade 26% 
av kroppens energiinnehåll förlorats 6 månader efter operation, motsvarande en 
negativ energibalans på 340 kcal per dag. Muskelmassa och arbetskapacitet var 
relaterade vid alla mätpunkter och förändringar i muskelmassa var också relaterade 
till förändringar i arbetskapacitet, medan energibalansen inte direkt påverkade 
förhållandet. Viktförlorande patienter i negativ energibalans förlorade dock mer 
muskelmassa och minskade sin arbetskapacitet jämfört med viktstabila patienter i 
energibalans. Ungefär en tredjedel av patienterna hade låg muskelmassa före 
operationen. 
 
Slutsatser: Viktminskning efter stor övre gastrointestinal kirurgi inträffade främst 
under den första månaden och fortsatte under hela det första året. Viktminskningen 
bestod främst av fett, och verkar hålla i sig eftersom viktsförlust i samma 
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storleksordning förelåg ännu fem år efter operation. Låg muskelmassa var vanligt 
förekommande. Viktutvecklingen var heterogen, ungefär 30% (studie B) till 50% 
(studie A) av patienterna ökade i vikt under interventionen. Förekomst av annan 
samtidig sjukdom och ett högre kroppsmasseindex (BMI >25) var faktorer som 
påverkade viktutvecklingen negativt. Muskelmassa och förändringar i muskelmassa 
påverkade arbetskapacitet. Betydelsen av energibalans för detta samband är oklar, 
men resultaten tyder på att viktförändring påverkar muskelutveckling och 
funktionsförmåga. 
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ABBREVIATIONS 
 
 
ASMM Appendicular skeletal muscle mass 
ASMMI Appendicular skeletal muscle mass index 
BF Body fat 
BFI Body fat index 
BMI Body mass index 
BW Body weight 
DLW Doubly labelled water 
DRM Disease related malnutrition  
DXA Dual energy x-ray absorptiometry 
EN Enteral nutrition 
ESPEN The European Society for Clinical Nutrition and Metabolism 
FFM Fat-free mass 
FFMI Fat-free mass index 
LOS Length of stay 
MET Metabolic equivalents 
MUGI Major upper gastrointestinal 
NCP Nutrition Care Process 
ONS Oral nutritional supplements 
PAEE Physical activity energy expenditure 
PAL Physical activity level 
PAR Physical activity ratio 
PN Parenteral nutrition 
REE Resting energy expenditure 
SD Standard deviation 
TBSMM Total body skeletal muscle mass 
TBSMMI Total body skeletal muscle mass index 
TEE Total energy expenditure 
TEF Thermic effect of food 
TG Total gastrectomy 
WL Weight losing group 
WS Weight stable group 
4D FR 4-day food record 
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INTRODUCTION 
 
 
The primary cause of malnutrition in developed countries is disease, hence the 
expression “disease-related malnutrition” (DRM) [1]. Effects of the disease itself 
and/or effects of treatment can led to anorexia, difficulties in eating and swallowing 
or in the digestion and absorption of food and hence, influence on patients’ food 
intake. A negative energy and nutrient balance will eventually result in metabolic, 
compositional, functional and psychological alterations that constitute the state of 
malnutrition. From a clinical point of view it is important to detect malnutrition at 
an early stage in order to prevent functional impairment and negative effects on 
clinical outcome, and enable less time- and resource-consuming interventions to be 
used effectively. Thus, the use of screening methods is advocated [2].  
 
Based on measurements of resting energy expenditure (REE), it was until recently 
believed that a primary cause of weight loss was increased energy expenditure. 
However, the true determinant of energy balance is the relation between energy 
intake and total energy expenditure (TEE). With the possibility to determine TEE 
using double labelled water (DLW) it was discovered that TEE is unchanged in 
many patient populations. Instead TEE may even be lower than normal due to a 
reduction in physical activity. Therefore, correction of a low nutritional intake may 
be one of the most effective methods to prevent and treat DRM. 
 
This thesis focuses on oral nutritional therapy and its effects on body weight, body 
composition and energy balance after major upper gastrointestinal surgery mainly 
due to cancer. 
 
Major upper gastrointestinal (MUGI) surgery is an advanced and complicated 
treatment. It leads to major anatomical changes in the gastrointestinal tract and 
approximately 85% of gastrectomized patients have been reported to suffer from 
eating-related symptoms [3]. 
 
Nutritional therapy is often used in this patient group to prevent or reduce the 
negative effects of disease and surgery on nutritional status. To minimize the 
burden of different eating-related symptoms and to optimize energy and nutrient 
intake from ordinary food and supplements individualised dietary counselling is 
practiced.  
 
However, there is a lack of evidence for the provision of oral nutritional therapy in 
managing DRM. There is also a lack of detailed descriptions of dietary counselling 
and oral nutritional therapy, which further complicates the interpretation and 
comparisons between different studies or populations [4].   
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Disease related malnutrition 
 
Malnutrition means bad or faulty nutrition. The term is used to denote deficiency, 
excess or imbalance of a wide range of nutrients in both the presence and the 
absence of disease. There are inconsistencies and also confusion about both the 
definition and criteria for diagnosis and classification. Although both under- and 
overnutrition are forms of malnutrition, the term is often used to refer only to 
undernutrition. This convention will be used in this thesis, so that the term 
“disease-related malnutrition” refers only to disease-related undernutrition. 
 
In the 1970s the problem of malnutrition in hospitals was recognized [5] and also 
the fact that most patients did not have their nutritional status examined during their 
hospital stay [6]. The former head of our department, professor Björn Isaksson, 
identified already in the 1980´s malnutrition in hospitals and denoted this state of 
nutrition as hospital related malnutrition [7]. He identified factors of importance to 
prevent malnutrition, i.e. provision of a catering system tailored to patients needs, 
provision of good tasting energy and nutrient dense foods, routine assessment of 
nutritional status at admission, identification of responsibility for nutrition care and 
the importance of education to medical students, doctors and ward staff in nutrition 
[7,8]. He also published guidelines for nutrition assessment and nutritional therapy 
[9]. Since that time progression has been slow in identification and treatment of 
malnutrition in most health-care systems. Today nutrition societies call for much of 
the same actions to prevent DRM, as Isaksson identified already 30 years ago [10]. 
 
Definition of DRM 
The lack of a standard definition of DRM gives rise to much confusion both 
concerning detection, prevalence and consequences of malnutrition and also the 
possibility to evaluate the effects of nutritional therapy. 
 
Malnutrition has been defined as “The imbalance between intake and requirement 
which results in altered metabolism, impaired function and loss of body mass” [11]. 
Allison proposed a clinical definition of undernutrition as “A state of energy, 
protein or other specific nutrient deficiency which produces a measurable change 
in body function, and is associated with a worse outcome from illness as well as 
being specifically reversible by nutritional support”. Already at the beginning he 
considered this definition incomplete because it failed to recognise; 1. Suboptimal 
nutrition i.e. diminished glycogen stores or an absence of semi-essential nutrients 
such as glutamine during critical illness or trauma 2. The effect of acute disease on 
nutritional risk as it threatens normal food intake for a prolonged period [12].  
Elia has defined malnutrition as “A state of nutrition in which a deficiency or excess 
(or imbalance) of energy, protein and other nutrients causes measurable adverse 
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effects on tissue/body form (body shape, size and composition) and function, and 
clinical outcome” [13].  
 
 
DRM develops through two parallel processes and the course is affected by the 
presence or absence of metabolic changes, collectively referred to as catabolism 
(figure 1). Systemic inflammation leads due to its catabolic action to loss of fat-free 
mass (FFM), primarily skeletal muscle mass. The magnitude of tissue loss is related 
both to the intensity of the inflammatory reaction and its duration in time and is 
considered crucial as it furnishes substrate to fuel and support the acute phase 
response in trauma/disease [14]. 
 
Reduced intake
Disease Weight loss
Catabolism
 
Figure 1.  Disease-related malnutrition develops by two parallel processes and the course is 
affected by whether the disease causes an inflammation response or not. 
 
 
Soeters et al [14] has recently proposed a definition that reflects this dual pathway  
pathophysiology of DRM and the possible contribution of diminished function 
from both abnormal body composition and inflammatory activity, “Malnutrition is 
a subacute or chronic state of nutrition in which a combination of varying degrees 
of over- or undernutrition and inflammatory activity have led to a change in body 
composition and diminished function”.  
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Diagnosing DRM 
Due to various conceptual definitions there is no consensus of the 
operationalisation of DRM i.e. “the development of a set of measurements that are 
a logic consequence of the definition of malnutrition and that should allow the 
assessment of nutritional state to be performed in a practical manner” [15] .  
Recently, an aetiology-based construct suggestion for the diagnosis of adult 
malnutrition was published [16]. The nomenclature for nutrition diagnosis is 
proposed to distinguish between chronic starvation without inflammation 
(“starvation-related malnutrition”), chronic inflammation of mild to moderate 
degree (“chronic disease-related malnutrition”), and acute inflammation of severe 
degree (“acute disease or injury-related malnutrition”). However, operationalisation 
for this diagnostic approach is needed before it can be used in routine clinical 
practice.  
   
The classification of malnutrition in the International Classification of Diseases 
(ICD) uses body weight expressed as standard deviation scores (z-scores) to 
diagnose malnutrition [17]. This approach is more suitable to children were the use 
of growth charts is a standard practice. The ICD does not include recent weight 
loss, recent intake, or inflammatory/disease-state which is all important factors in 
DRM.  By adding cut-off’s for BMI and unintentional weight loss in combination 
with a suboptimal intake, Australia have released a revised national version of the 
ICD-10 diagnosis of malnutrition adjusted with criteria for diagnosing DRM in 
adults [18]. Following criteria and cut-offs are used in the operationalisation of 
DRM and its severity; 
 
• E43 Unspecified severe protein-energy malnutrition 
o BMI < 18.5 kg/m2 or unintentional loss of weight (>10%) with 
evidence of suboptimal intake resulting in severe loss of subcutaneous 
fat and/or severe muscle wasting 
• E44.0 Moderate protein-energy malnutritition 
o BMI < 18.5 kg/m2 or unintentional loss of weight (5-9%) with 
evidence of suboptimal intake resulting in moderate loss of 
subcutaneous fat and/or moderate muscle wasting. 
• E44.1 Mild protein-energy malnutrition 
o BMI < 18.5 kg/m2 or unintentional loss of weight (5-9%) with 
evidence of suboptimal intake resulting in mild loss of subcutaneous 
fat and/or mild muscle wasting. 
 
 
The study of Meijers et al [15] among nutrition stakeholders concluded that a 
definition of DRM should include at least the elements deficiency of energy, 
deficiency of protein and decrease in fat-free mass. Also, function and 
inflammation are suggested to be important. Criteria for diagnosis of DRM were 
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suggested to include at least the elements involuntary weight loss, BMI and 
nutritional intake. However, in this study there were disagreements on the level of 
importance of the elements and also regarding cut-off values. 
 
Identification of DRM 
In clinical practice, a variety of screening methods to detect DRM exists. A 
screening test refers to the detection of an otherwise unrecognised condition, which 
is usually amenable to treatment. Screening refers to a simple, rapid and general 
test that is undertaken by nursing, medical and other staff, often at first contact with 
patients, in order to identify those at risk of malnutrition. A recent review identified 
over 70 tests or tools for detection of malnutrition [19]. These tools vary 
significantly in their validity and reliability and also in applicability and usefulness 
[19].  However, since there is no universal agreement about the definition there is 
also a lack of reference methods to evaluate different screening tools. According to 
The European Society for Clinical Nutrition and Metabolism (ESPEN), the purpose 
of nutritional screening is to “predict the probability of a better or worse outcome 
due to nutritional factors, and whether nutritional treatment is likely to influence 
this”. In 2003 ESPEN published a guideline for how undernutrition or risk for 
development of undernutrition can be detected [20]. Since screening method may 
vary according to circumstances, e.g. age or type of illness, they recommend 
different screening methods for the community, hospitals and in the elderly. Aware 
of the fact that no screening method has yet been validated with respect to clinical 
outcome, they state that these recommendations may need modification in the light 
of future experience. 
 
In a recent review of the evidence for the impact of improving nutritional care it 
was found that nutritional screening alone is insufficient to achieve changes in 
outcome. Instead there is a need for suitable interventions to follow detection of 
patients with or at risk of malnutrition [21]. However, before initiation of 
nutritional therapy it is important to assess nutritional status and identify and label 
the nutritional problem with a nutrition diagnosis to be able to provide right 
treatment to right patient. 
 
Prevalence of DRM 
Reported prevalence varies according to use of different measures and 
methodology, cut-offs values, patient characteristics, medical diagnosis, and health-
care settings [22]. There is also confusion about the prevalence since some studies 
report on the risk for malnutrition and not on malnutrition per se. Using body mas 
index (BMI) < 20 kg/m2 as an indicator of risk for malnutrition, a mean estimated 
prevalence of underweight of approximately 18% (range 5%-37.5% has been 
reported in patients admitted to hospital with mixed diagnoses [1]. If unintentional 
weight loss is used, which has been identified as a better predictor of outcome than 
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BMI [23], an weight loss of >10% usual body weight is reported in up to 58% of 
general gastrointestinal surgical patients [1].  
 
Based on 25 Swedish studies in health care settings (n = 5120) during 1980-1990's, 
the mean prevalence of protein and energy malnutrition was reported to be 
approximately 30% (range 5-87%). Four out of these 25 studies were performed on 
surgical patients (n = 558) and a prevalence of 40% (range 12-87%) were reported 
[24].  
 
Unfortunately, development of malnutrition is not only a problem before hospital 
admission. Patients also develop malnutrition, or worsen an already existent 
malnutrition, during their hospital stay [22,25]. 
 
Consequences of DRM 
Malnutrition has a diversity of effects, influencing every system of the body [1]. 
DRM is associated with impaired immune function, delayed wound healing and 
convalescence from illness and decreased functional status [26]. This affects the 
length of stay (LOS), outcome of medical care, survival and hence the costs to 
society [1,26]. DRM leading to prolonged LOS and increased complication rates 
also affect hospital costs. From studies that have investigated the impact of poor 
clinical outcome due to malnutrition, increased hospital costs of 26 to 77% have 
been reported [1]. 
 
 Nutrition care process 
The reasons why patients fail to meet their energy and nutrient needs are multi-
factorial and include patient-specific factors, as well as factors related to the care 
system, such as provision of catering and clinical practice routines [21].  
 
The guideline on nutrition screening from ESPEN [20] includes standards on 
screening at admission, assessment of undernourished patients, initiation of  
nutritional therapy, monitoring of outcome, communication of results and creating 
a patient care plan. A wide discrepancy between standards for nutritional routines 
and clinical practice in screening, assessment and initiating treatment has been 
identified in the Nordic countries [27]. Insufficient knowledge was pointed out by a 
great number to be the main barrier for good nutritional management [27].  
 
Hospital and health care organizations should have a comprehensive hospital joint 
policy on how nutritional care should be designed [20]. This policy should include 
all steps in the nutrition care process (NCP); 
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Screening 
↓ 
Assessment 
↓ 
Treatment 
↓ 
Monitoring and evaluation 
↓ 
Communication 
 
 
Each step in the process should be continuously documented, in the same way as 
any other part of the medical treatment. To ensure safe and effective nutritional 
care, the process needs to be standardized, established in the daily care routine and 
well known by all health care personal involved.  A multi-professional approach is 
likely the most beneficial [10,21]. Since length of stay in acute care settings is 
limited and treatment of DRM is time-consuming, communication to other health 
care professionals when the patient is transferred is of great importance.   
 
As indicated in the ESPEN guidelines on enteral nutrition, clinical processes can 
only be effectively implemented if there is a robust infrastructure [10]. Key 
elements mentioned for such a robust infrastructure on nutritional care are:  
 
 
• Basic routines for nutritional care 
• Identifying patients nutritional needs 
• Providing individualised nutritional care when appropriate 
• Making the most out of hospital food 
• Choosing the right products 
• Multi-professional working 
• Communication and documentation 
• Organisation and logistics 
• Financial management 
• Education 
• Training 
 
 
According to the American Dietetic Association (ADA) the NCP is intended to 
establish a standardized process for providing care [28]. This process is specific for 
the dietitian and involves four steps; nutrition assessment, nutrition diagnosis, 
nutrition intervention and nutrition monitoring and evaluation.  A nutrition 
diagnosis identifies and labels a nutritional problem that the dietitian is responsible 
for treating independently [28]. It is distinct from the medical diagnosis. The 
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importance of each step is highlighted since each step of the NCP is mandatory and 
informs the subsequent step. However, as new information is obtained the previous 
steps has to be revisited to reassess, add or revise nutrition diagnoses, modify 
interventions, or adjust goals and monitoring parameters [29]. For nutritional 
therapy to be successful, it is of equal importance to set the right nutrition diagnosis 
as the proper medical diagnosis is for adequate medical treatment.  
 
Nutrition therapy in DRM 
There is increasing evidence that insufficient food intake is of central importance in 
the development and progression of DRM [1]. Therefore, increasing energy and 
nutrient intake may be one of the most effective methods for prevention and 
treatment of DRM.  Nutritional intake has also been identified as an important 
factor for outcome. Based on the one-day cross-sectional audit, NutritionDay in 
2006, a progressive increase of 30-day mortality was associated with a reduced 
food intake [30].  
 
In this thesis the focus is solely on nutritional therapy for prevention and treatment 
of DRM. Although the dual pathway pathophysiology of DRM – low intake and 
catabolism – may require multimodal strategies to combat, adequate nutritional 
intake is essential under all circumstances for an over all successful treatment of the 
patient. 
 
Normal food should always be the first option when feeding the patients if not 
strong contra indication for oral intake exists [10,31]. By providing good quality 
food, appropriate in amount of energy and nutrients and consistency [32], and 
eating assistance when needed, many patients can meet their nutritional needs [33]. 
It is also important that meals are not missed and that restrictions on intake related 
to investigations or surgical procedures are minimized.  
 
However, if the ordinary food served at the ward is not enough, nutritional therapy 
may be indicated. The overall aim of nutritional therapy is to try to ensure that total 
energy and nutrient intake meet the patients’ needs (ordinary food + support) [33]. 
Strategies for nutritional support include oral nutritional supplements1, food 
fortification1, energy supplements1, enteral tube feeding1 and parenteral feeding 
(figure 2). Some clinical guidelines exist on a national level for treatment of DRM 
[24,33,35]. ESPEN provides disease-specific or treatment-specific guidelines for 
enteral and parenteral nutrition, as for example in surgery [36,37]. 
 
Dietary counselling, usually performed by a registered dietitian, is a supportive 
process, characterized by a collaborative counsellor-patient/client relationship, to 
set priorities, establish goals, and create individualized action plans that 
                                               
1
 Ref 34. Commission directive 1999/21/EC: Dietary foods for special medical purposes. 
 19
acknowledge and foster responsibility for self-care to treat an existing condition 
and promote health-supportive process [28].  
 
In a patient able to eat but in quantities insufficient to meet requirements, oral 
nutritional therapy is usually the first step in the provision of nutritional therapy. 
The aim is to increase energy and nutrient intake primarily from food. This has the 
potential advantages to offer a greater variety in taste and texture and the possibility 
to be tailored to individual preferences. Oral nutritional therapy can also be offered 
at a lower cost and requires less technical equipment and surveillance compared to 
artificial nutrition.  
 
By individually tailored prescriptions oral nutritional therapy are adjusted to meet 
individual eating habits, preferences and physiological and energy/nutrients needs. 
Oral nutritional therapy can be divided into two sections (figure 2). 1) diet therapy 
aims to optimize the intake of energy and nutrients from ordinary foods and adjust 
diet to better tolerate side effects of the disease or its treatment, e.g. consistency of 
diet [32], special diets [38], and energy and protein enriched diet [35]. When food, 
despite these adjustments, in not enough to cover energy and nutrient needs the use 
of 2) “dietary foods for special medical purposes” [34] and/or vitamin and mineral 
substitution is initiated. Dietary foods for special medical purposes are “intended 
for the exclusive or partial feeding of patients with a limited, impaired or disturbed 
capacity to take, digest, absorb, metabolise or excrete ordinary foodstuffs or certain 
nutrients contained therein or metabolites, or with other medically-determined 
nutrient requirements, whose dietary management cannot be achieved only by 
modification of the normal diet, by other foods for particular nutritional uses, or by 
a combination of the two” [34]. “Dietary foods for special medical purposes” can 
either be consumed directly via oral intake (oral nutritional supplements and energy 
supplements), or as enteral nutrition (“feeding provided through the gastrointestinal 
tract via a tube, catheter, or stoma that delivers nutrients distal to the oral 
cavity”[39]) or added to food or drink as Food fortification [40]. 
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nutrition
1 Commission directive 1999/21/EC: Dietary foods for 
special medical purposes, ref 34
2 Specific nutrients, in particular energy and/or proteins, 
minerals,vitamins, trace elements intended to enrich food. 
Synonyms used in the literature: enriched food, ref 41
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Figure 2.  Structure of nutritional therapy. 
 
 
The evidence base for the effects of nutritional therapy has been strengthened in 
recent years but this applies mainly to oral nutritional supplements (ONS), enteral 
nutrition (EN) and parenteral nutrition (PN) and not to dietary counselling or other 
measures carried out to increase intake of energy and nutrients from food [1,21,41]. 
Therefore much less is known about diet therapy and its curative and preventive 
effects in DRM. However, two recently prospective, randomized controlled trials in 
cancer patients on radiation therapy compared dietary counselling based on regular 
food, to both ONS and also to a control group. Dietary counselling led to a 
persistent increase (at 3 months) in energy and protein intake and this was opposite 
to ONS and the control group [42,43]. In these studies dietary counselling 
improved patients’ nutritional status and QoL, thereby lessening radiation related 
morbidity. Another study randomized patients to receive either nutrition 
intervention based on a predetermined standard nutrition protocol (the Medical 
Nutrition Therapy, cancer/radiation oncology, protocol of the American Dietetic 
Association) or to standard care. Patients receiving nutrition intervention 
experienced less deterioration in weight, nutritional status and global quality of life 
compared to patients receiving standard care [44]. 
 
Also, meal fortification and additional snacks have been shown to increase energy 
intake in elderly institutionalized elderly [45-48]. In a study of malnourished 
patients admitted to medical or surgical wards who received two in-between meals 
and energy- and protein enriched meals, intake increased with 600 kcal and 12 g 
protein per day.  
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In many studies of DRM, nutritional therapy has been shown to improve nutritional 
status or clinical outcome. A combined meta-analysis of ONS and enteral tube 
feeding studies [1] across different patient groups and health-care settings showed 
significant reductions in mortality and complications rates. From this meta-analysis 
it was shown that reduction in length of hospital stay occurs in most trials. 
Improvements in body weight, although small, is seen especially in patient groups 
who are initially underweight (BMI <20). However, there is little evidence at 
present to suggest improvements in function or clinical outcome from fortification 
and counselling [41]. There is certainly a need of well-designed trials that 
investigates different strategies to improve dietary intake.  
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Body composition and energy metabolism 
 
Body weight 
Body weight measured on a scale is a practical and simple measure of the sum of 
total body components. Body weight adjusted for height [weight (kg)/height (m)2] 
is a crude estimate of body energy stores, and is widely used to estimate nutritional 
state. Changes in body weight are determined by changes in body energy content 
(mainly fat and protein, and to a small extent glycogen), and changes in body water 
(and, to a minor extent minerals). Changes in energy content reflect the balance 
between energy intake and energy expenditure, and if hydration is assumed to be 
unchanged, body weight change is an estimate of energy balance. A weight loss 
>10% within the previous 3-6 months is considered as a clinically relevant weight 
loss [1] and is used in several screening instruments. 
 
Body composition 
The study of human body composition can be defined as “a branch of human 
biology which mainly focuses on the in vivo quantification of body components, 
the quantitative relationships between components, and component alterations 
related to various influencing factors” [49]. In this thesis, alterations in body 
composition related to disease and nutritional therapy have been explored.  
 
The components of the human body can be organized into five separate body 
composition levels; a sum of all atoms, molecules, cells, all tissues/organs in the 
body or the whole body [49]. Body mass (weight) is the sum of the components at 
each of the five levels. Each level and its multiple components are distinct, but 
biochemical and physiological connections exist such that the five levels are 
consistent and function as an entity. There are relatively few direct measures of 
body composition. However, in a steady-state of body composition, relatively 
constant relationships are maintained between components at the same or different 
levels. This provides a matrix for creating explicit body composition equations, and 
development of multi-compartment methods for use when measuring the body 
composition indirect, and enables the estimation of body composition at different 
levels from one or more measurable properties of components. 
  
Direct measures 
The whole-body content of most frequently occurring atoms in the body can be 
measured in vivo as for example potassium by whole-body counting. At the 
molecular and cellular level total body water and the volume of extra cellular fluid 
can be measured by isotope-dilution techniques and bone mineral can be measured 
by whole-body dual-photon absorptiometry and dual energy x-ray absorptiometry 
(DXA). No direct measure of cellular mass or extracellular solids exists. On the 
organ/tissue level most information comes from cadaver studies or tissue biopsies. 
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Imaging techniques, as Computerized tomography or Magnetic Resonance 
Imaging, are the main methods at this level. On the whole-body level, 
anthropometric measures such as body weight, body height, skin-folds, 
circumference and body volume can be measured directly. 
 
Indirect measures 
For indirect measure of body composition a large number of methods and models 
have been described. These methods vary widely in terms of availability and 
suitability for clinical use, as well as in precision and accuracy for determination of 
different body components and compartments. The choice of method in this study 
was based on availability and suitability for the groups studied, and a need for high 
precision to enable the study of relatively small changes in a limited sample. DXA's 
ability to measure small changes in body composition is supported by recent 
research findings [50]. 
 
Dual energy x-ray absorptiometry 
DXA allows the body to be described as a 3-compartment model of mineral, 
mineral free soft tissue and fat. Measurements are made in the anteroposterior 
position and a series of transverse scans is made from head to toe at ~ 1 cm 
intervals (pixel) over the entire scan area. Whole body and regional measures of the 
three components can be made.  
 
DXA uses a source that generates X-rays at two different energies, a detector and a 
computer system for imaging the scanned areas of interest. The principle of the 
method is that soft tissue and bone attenuate X-rays to different degrees. The body 
is divided into a series of pixels, and within each pixel the attenuation is measured 
and the ratio of the attenuations at these two energies is referred to as the R value. 
DXA assumes that the three different components are distinguishable by their X-
ray attenuation properties. Soft tissue reduces X-rays to a much lesser extent than 
does bone mineral, and bone mineral are relatively easily distinguished form those 
with no bone present. Suitable calibration allows fat and lean fractions to be 
resolved from soft tissue pixels. The composition of these areas of soft tissue is 
extrapolated to the soft tissue overlying bone to produce total body fat and lean soft 
tissue. The algorithms to accomplish these extrapolations vary between 
manufacturers.  
 
The advantages of DXA are that it is relatively quick; the whole body scan takes 
about 15 minutes or less. Radiation doses are low and DXA are used widely for 
subjects of all ages. Disadvantages are that the method assumes that hydration of 
fat-free tissue remains constant at 73% and severe over-hydration, such as ascites 
and oedema, may affect the resulting percentage of fat. Different manufacturers use 
different forms of calibration and different proprietary software solutions for the 
calculation of soft tissue composition in bone pixels, most often using the 
composition of soft tissue pixels adjacent to the bone pixel.  
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The precision of DXA are generally very good, with coefficients of variation of 
about 1% for bone mineral content, 2-3% for fat and 1% for lean soft tissue [50], 
but the accuracy is often considered due to the disadvantages described above, 
especially that values may vary slightly between manufacturers, devices and 
software versions.  
 
Total body skeletal muscle mass 
Based on the fact that a large proportion of total body skeletal muscle mass 
(TBSMM) is found in the appendages, and that the appendicular skeletal muscle 
mass (ASMM) is closely related to TBSMM, Kim et al [51] developed a TBSMM 
prediction model based on DXA measurements of arms and legs. The equation was 
validated against the reference method for total and regional muscle mass, magnetic 
resonance imaging. Later on the equation was refined considering inter- and 
intramuscular adipose tissue [52]. Although small in quantities (~1-2 kg), the 
presence of intramuscular adipose tissue within the skeletal muscle may bias the 
estimate of TBSMM.  
 
Total energy expenditure 
Total energy expenditure (TEE) is commonly divided in three components, resting 
energy expenditure (REE), physical activity energy expenditure (PAEE) and the 
thermic effect of food (TEF). REE, the energy required for basal, postabsorptive 
metabolism, is the largest component comprising 60-75% of TEE [53]. PAEE, the 
energy required to support physical movement, is the most variable component of 
TEE ranging from as little as 10% during bed rest or as much as 50% in elite 
athletes [53]. On average PAEE compromises 15-30% of TEE [53]. TEF represents 
the energy used to digest, metabolize and store ingested food and usually accounts 
for 10% of TEE [53]. 
 
DLW measures TEE in unrestrained humans in their normal surroundings over a 
time period of 1-4 weeks. It is regarded as the reference method for validation of 
other methods to assess physical activity and energy intake. DLW has an reported 
accuracy of 1-3% and a precision of 2-8% [54].  
 
The principle of the method is that after a loading dose of water labelled with both 
stable isotopes of hydrogen (deuterium, 2H) and oxygen (18O), deuterium 
equilibrates throughout the body’s water pool, and 18O equilibrates in both the 
water and the bicarbonate pool. The bicarbonate pool in turn equilibrates to the flux 
of carbon dioxide, which, together with water, is the end product of energy 
metabolism and is eliminated through the lungs. Consequently, deuterium is 
eliminated as water, while 18O is eliminated as both water and carbon dioxide. The 
elimination rates of deuterium and 18O  from the body are measured by mass 
spectrometric analysis of body fluid samples: blood, saliva or urine [55]. The 
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difference between the two elimination rates is a measure of carbon dioxide 
production. This indirect measure of metabolic rate may then be converted to units 
of heat production by incorporating knowledge, or estimates, of the chemical 
composition of the foodstuffs being oxidized since this influences the energy 
equivalence of each litre of CO2 produced.  
 
The DLW method involves several assumptions about the behaviour of the 
isotopes, the body water pool and the exchange rates within that pool in the labelled 
subject [55]: 
 
 
• The volume of the body water pool remains constant throughout the 
measurement period. 
• The isotopes label only water and carbon dioxide in the body. 
• The rates of water and carbon dioxide flux are constant during the 
measurement period. 
• The isotopes leave the body only in the form of water and carbon dioxide. 
• The concentrations of isotopes in the water and carbon dioxide leaving the 
body are the same as those in body water at that time (i.e. no fractionation). 
• The background levels of the isotopes remain constant throughout the 
measurement period. 
 
 
After the introduction of DLW in humans, it has been applied in studies to measure 
TEE in some disease states. Combining TEE with measures of REE permits the 
calculation of PAEE and this has broaden our understanding on the impact of 
disease on energy balance. Available studies suggest that TEE is unchanged or 
even reduced during different disease states. This is mainly explained by a 
reduction of PAEE. Thus, reduced energy intake rather than increased energy 
expenditure appears to be the likely mediator of the negative energy balance and 
ensuing weight loss seen in many disease states (Table 1). 
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Table 1. The doubly labelled water technique has offered the possibility to investigate the 
effects of disease on the components of energy metabolism in disease and hence, energy 
balance.   
Reference Population REE PAEE TEE 
Goran [56] Burns (children) 
n=15 
↑ ↓ ↔ 
 
Casper [57] Anorexia Nervosa 
n=6 vs 6 contr 
↓ ↑ ↔ 
 
MacAllan [58] AIDS  
n=27 
↑  ↓ ↔ 
↓ BW-loss 
Heijligenberg [59] AIDS 
n=9 vs 9 contr 
↑ ↔ 
 
↔ 
 
Toth [60] Heart failure 
n=26 vs 50 contr 
↔ 
 
↓ ↓ 
Toth [61] Parkinson’s disease 
n=16 vs 46 contr 
↔ 
 
↓ ↓ 
Poehlman [62] Alzheimer’s disease 
n=30 vs 103 contr 
↓ ↓ ↓ 
Moses [63] Advanced pancreatic cancer 
n=24 
↑ ↓ ↓ 
Delikaniki-Skaribas [64] Parkinson’s disease 
n=10 weight losing vs n=10 weight stable 
↔ 
 
↔ 
 
↔ 
 
 
 
Resting energy expenditure 
REE is the largest component of energy expenditure, usually accounting for half to 
three-quarters of TEE. REE should be measured under standardized conditions i.e. 
in an awake, relaxed and overnight fasted state. The major part of whole-body REE 
(approximately 65%) stems from organs with high metabolic activity such as the 
liver, brain, heart and kidneys [53]. REE is closely related to body size, and thus 
standard values for energy expended or oxygen consumed can be given per unit of 
body weight.  
REE is more variable in disease than in health and is influenced by the type, 
severity, phase of illness, nutritional status and a wide range of treatments [65]. 
Therefore, prediction of REE from standard reference tables or equations is more 
likely to be in error in disease than in health. 
 
Thermic effect of food 
TEF is mainly due to the energy cost of nutrient absorption and storage and 
increases significantly after a meal. The total TEF is approximately 10% of TEE 
but varies with the composition of the diet and is greater after consumption of 
carbohydrates and protein than after fat.  
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Physical activity energy expenditure 
Physical activity can be defined as any bodily movement, produced by skeletal 
muscles, that results in increased energy expenditure [66]. Total amount of energy 
expenditure is determined by the amount of muscle mass producing bodily 
movements and the intensity, duration and frequency of the physical activity. The 
most important source of variation in energy expenditure between individuals is the 
muscular activity.  
For a single activity the intensity can be expressed as metabolic equivalents (MET) 
or as physical activity ratio (PAR). A MET represents the ratio of energy expended 
at a particular activity divided by REE (measured or calculated) (1 metabolic 
equivalent=1 kcal kg-1 h-1 or 1MET=3,5ml O2 kg-1 min-1) and PAR is the total 
cost of an activity divided by basal metabolic rate. A compendium of energy costs 
of physical activities was published in 1993 [67] to facilitate the coding of physical 
activities and to promote comparability of coding across studies. In 2000 an 
updated version of the compendium was published and contains 605 specific 
activities [68]. The World Health Organization uses PAR in its physical activity 
index to express energy cost of activities (requirements per minute for various 
occupations) [69]. 
 
For a whole day the average intensity is expressed as physical activity level 
(PAL=TEE/REE) and can be described as light, moderate or heavy [69].  
 
Different methods used to measure physical activity and energy expenditure 
include behavioural observations, diaries, physiological markers like heart rate, 
calorimetry (none of the former methods will be discussed in this thesis), recall 
questionnaires/interviews and motion sensors.  
 
Dietary intake 
Determination of dietary intake can either be done using prospective or 
retrospective methods. The choice of method depends on the purpose for which 
data will be used. Different dietary assessment methods give data on different 
output levels. Other factors of importance are resources in time, money, 
competence, population and population size. It is also important to interfere as little 
as possible with normal life but at the same time get as detailed descriptions as 
possible of food intake. 
 
In prospective methods food intake is recorded at the time of eating, so called food 
records. Individuals note every food, snack or beverage consumed. Intake can 
either be weighed or estimated by households’ measures or photographs/models. 
Shorter or longer periods of food intake can be recorded, usually over a period of 3-
14 days [70].  To obtain representative data from an individual, the record must 
comprise several days and cover the true daily, weekly and seasonal variability in 
food intake. Another condition is that type and amount of food eaten are well 
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described which requires a great accuracy of the person recording the food intake. 
Daily variation is the main factor determining the precision of recording methods 
and the extent of variation depends on the nutrient considered [71]. An average 
within-person day-to-day coefficient of variation for energy intake is reported to be 
20-30% [72]. 
 
Retrospective methods rely on the memory of participant to recall food and diets 
eaten in the past. The methods used are recall of foods eaten, food frequency 
questionnaires, and diet history interviews.  
 
Diet recalls are designed to quantitatively assess recent food intake in an individual 
by means of an interview. The most common is 24-hour recall although recalls 
from separate meals up to 7-days have been used [73].  
 
Food frequency questionnaires were first developed for use in epidemiological 
investigations. They aim to estimate how often certain types of food are eaten.  
They can cover total intake or focus on specific groups of food or nutrients and also 
exclude or include information of portions sizes [74].  
 
Diet history interviews require trained interviewers and are time-consuming. The 
method aims to capture habitual food intake during a specified period. The 
interview often starts with a 24 hour recall. To obtain an impression of how 
frequently particular foods is used and details of cooking methods the interviewer 
uses a questionnaire/checklist and for estimation of quantities photographic aids, 
food models or households measures is used [72].  
 
In two reviews investigating validity of self-reported energy intake against DLW 
under-reporting was frequently observed [70,75].  The under-reporting was not 
confined to only one method but occurred across all dietary assessment methods 
[70,75]. It was originally believed that the phenomenon of under-reporting was 
linked to increased adiposity and body size but the most important mechanism for 
under-reporting in most age-groups appears to be “attitude to food”. This includes 
factors like body image, weight consciousness, social expectations and dietary 
restraint (a tendency to consciously control food intake in order to assist weight 
loss or prevent weight gain [75]). Gender, socioeconomic status and motivation 
also play a role in under-reporting.  
 
There are very few criterion methods against which self-reported intake can be 
validated. Instead validation has involved comparison of one instrument against 
another. As such, it is the relative validity that is then examined. This type of 
validation will fail to detect true reporting bias if the two instruments have 
correlated errors. Instead, an external method with unrelated sources of error such 
as DLW is preferred for validation of recorded energy intake. The error of the 
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DLW technique is independent of self-reported intake error and true reporting bias 
can thus be detected [70].   
 
Energy balance 
As stated earlier changes in energy content of the body reflect the balance between 
energy intake and energy expenditure: 
 
Energy intake - energy expenditure = change in body energy stores [76]. 
 
If energy intake equals energy expenditure there is no change in body stores and 
energy balance is achieved. However, if energy expenditure does not equal energy 
intake there is a simultaneous change in body stores and thus body weight. If 
hydration is assumed to be unchanged, body weight change is an estimate of energy 
balance.  
However, change in body weight does not provide information on the composition 
of the lost body mass. The energy content of body mass depends on the ratio 
between fat-free mass and body fat since the energy density of body fat is 
approximately 10 times higher than that of fat-free mass [77].  
The energy density of fat is well established at 39.4 MJ/kg, but the energy density 
of FFM, often taken as 3.7 MJ/kg [77] may be somewhat more variable due to 
variations in the proportions of protein and to a small extent glycogen in relation to 
water and mineral. Ideally, the energy containing components of FFM, i.e. protein 
and glycogen, should be quantified to obtain an exact measure of its energy 
content. This requires very complex methods in vivo, but due to the large 
differences in energy density between fat and fat-free mass mentioned above, 
variations will generate very small errors for total body energy content, except 
perhaps in very extreme situations of depletion.  
We aimed to maximize utilization of the information obtained from DXA, and thus 
calculated the energy content of FFM on an individual basis as the sum of protein 
and glycogen, both with an energy density of 17 MJ/kg [69]. The sum of protein 
and glycogen was derived as FFM minus total body water (assumed constant at 73 
% of FFM) and mineral (as the sum of bone mineral from DXA and soft tissue 
minerals, assumed constant at 1.29 % of total body water [78]. An independent 
measurement of total body water may have further improved the precision of this 
calculation, but was not available in the present study. 
In most circumstances, except in total or pronounced starvation, energy balance is 
close to zero, or at least numerically much smaller than its components energy 
intake and expenditure. This also forms the basis for validation of energy intake 
measurements from total energy expenditure by DLW. Given the large 
measurement errors of especially energy intake measurements in humans under 
free-living conditions, energy balance cannot be reliably calculated from its 
components. The concept of using differences in body composition at two or more 
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points in time offers a very precise way of determining long-term energy balance in 
free-living humans and groups of patients. 
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Upper gastrointestinal cancers 
 
 
As for most malignancies, gastric, oesophagus and pancreatic cancers are mainly 
diseases of the older age groups, with more than 80% of new cases in Sweden 
being over 60 years of age at diagnosis [79].  
Gastric cancer 
Gastric cancer is the fourth most common cancer worldwide [80]. It is a disease 
with a high death rate making it the second most common cause of cancer death 
worldwide after lung cancer [81]. It is more common in men and in developing 
countries [80].  
 
In Sweden, gastric cancer accounted for 1.7% in men and 1.3% in women of all 
new cancer cases in 2008 [79]. There is a remarkable decrease in upper digestive 
tract cancer incidence, which is mainly attributable to a reduction in gastric cancer, 
during the latest 20-year period (incidence rate 1989, 36.9/100 000 and incidence 
rate 2008 20.6/100 000). The decreasing trend has been constant since the start of 
the incident-registry in 1958. In 1960 gastric cancer was in second place of 
malignancies, and in 2008 it was no longer among the ten most common cancer 
forms in Sweden. This positive trend is assigned to changes in dietary habits, 
improvements in preservation and storage of food and a reduced prevalence of 
Helicobacter pylori [82].  
 
Cancer is the second leading death cause in Sweden but mortality from gastric 
cancer has steadily declined over the period 1987-2007 for both men and women 
[83]. Survival from gastric cancer is fairly good only in Japan (52%) where mass 
screening has been practiced since the 1960s [80]. The prognosis of gastric cancer 
in Europe and the United States is still rather poor because of late diagnosis and 
advanced stage at diagnosis [80]. In Sweden the 5-year survival rate following 
diagnosis of gastric cancer is around 20%. After surgery and with the addition of 
radiation therapy and/or chemotherapy the 5-year survival rate is approximately 
50% [82].  
 
Gastric cancer is often asymptomatic or causes only nonspecific symptoms in its 
early stages. By the time symptoms occur, the cancer has often metastasized to 
other parts of the body, one of the main reasons for its poor prognosis. Frequent 
symptoms that affect food intake and induce weight loss are loss of appetite, nausea 
and abdominal pain. The only treatment for cure is surgery. Average preoperative 
losses of 3-11% of pre-illness body have been reported [84-91].  
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Oesophageal cancer 
Oesophageal cancer is the eighth most common cancer world wide and the sixth 
most common cause of death from cancer [80]. Cancer of the oesophagus has a 
very poor prognosis with a 5-year survival of about 10 % of the cases in Sweden 
[82]. Oesophageal cancer is not common in Sweden, comprising only  0.8 % of all 
new cancer cases in 2008 [79]. It is more than twice as common in men [79]. 
Tobacco and alcohol are main contributors to its development in Europe and North 
America [80]. Recently, there appears to be an increase in western countries of 
adenocarcinomas of the oesophagus. The most likely explanation seems to be the 
increasing prevalence of Barrett’s oesophagus as a consequence of gastro-
oesophageal reflux, which is becoming more common with increasing levels of 
obesity [80]. 
 
The disease stage determines treatment options and surgery is the preferred 
treatment for resectable disease [92]. In Sweden only 25% of the patients suffering 
from oesophagus cancer are candidates for surgery and the reported 5 year survival 
after oesophagectomy is 31% [93]. One common identified nutritional problem in 
patients awaiting an oesophagoectomy is dysphagia.  
 
Pancreatic cancer 
Pancreatic cancer is the eight most common cause of death world wide from cancer 
[80]. 1.5% of all new cancer cases in Sweden 2008 were pancreatic cancer and the 
relative 5 year survival was 3.8% for men and 4.1% for women [82]. Little is 
known of the etiology of pancreatic cancer but there is a strong relationship to 
tobacco smoking and chronic pancreatitis increases the risk twenty-fold [82]. 
 
Symptoms of pancreatic cancer are diffuse and are often detected in a late stage of 
the disease. The only treatment for cure is surgery and about 15% of the patients 
are candidates for surgery. However, almost 90% of these patients relapse sooner or 
later [82], although 5-year survival rates up to 25% has been reported after surgical 
resection [94].  
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Major upper gastrointestinal surgery, nutritional 
status and outcome 
 
 
In gastric cancer patients body weight losses of 4-15% during the first year after 
surgery have been reported [84,89,91,95-104]. Suggested causes include 
postoperative symptoms such as early satiety, postprandial fullness, dysphagia, and 
dumping syndrome leading to a diminished food intake. Malabsorption of fat 
caused by loss of digestive enzymes of the stomach, decreased stimulation of 
pancreatic and biliary secretions, increased intestinal motility and bacterial 
proliferation within the small bowel [105] adds up to a mean energy loss of a few 
hundreds kilocalories per day in gastrectomized patients [100,106,107]. The 
perioperative weight loss appears to be difficult to regain and leads to a prolonged 
or persistent weight reduction in many patients [86,88,91,95,99,100,102,104,108-
111]. 
 
In the late 80s Windsor and Hill [112] showed weight loss to be a basic indicator of 
surgical risk provided that it is associated with clinically obvious impairment of 
organ function. Based on a clinical assessment of weight loss and functional status 
they found that patients with a weight loss >10% and abnormal function had a 
significantly higher incidence of major complications, septic complications, 
pneumonia and a longer hospital stay compared with patients with a weight loss 
<10% or >10% but with a normal function. They concluded that only patients with 
an impairment of important bodily functions in addition to significant weight losses 
should be considered for preoperative nutritional repletion.  
 
The general indication for nutritional therapy in the surgical patient are the 
prevention and treatment of undernutrition, i.e. correction of undernutrition before 
surgery and the maintenance of nutritional status after surgery [36].  
 
In the immediately postoperative state postoperative interruption of oral nutritional 
intake after MUGI surgery is frequently seen. The routine is believed to protect the 
anastomosis, prevent severe bloating and distension. However, this policy is not 
evidence-based and the risks or benefits of early initiation of food are unclear [36]. 
A questionnaire survey in 5 European countries revealed a marked heterogeneity in 
practice with particular reference to nutrition and oral intake and this is probably a 
reflection of the paucity of evidence [113]. Up to date, three studies have compared 
the routine ”nil-by mouth” the first days after MUGI surgery to “food-at-will” the 
first or second day after surgery [114-116]. No differences in morbidity were found 
but ”food-at-will” led to a faster onset of flatus/resumed bowel function, reduced 
length of stay, reduced wound infections and weight loss. ”Food-at-will” is 
suggested to promote faster postoperative recovery and a better quality of life for 
patients and through the activation of normal digestive reflexes it may elicit an 
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important impact on gut recovery, which is central in  overall recovery after MUGI 
surgery [36,115]. According to ESPEN Guidelines the amount of initial oral intake 
should be adapted to the state of gastrointestinal function and to individual 
tolerance and interruption of nutritional intake is pointed out to be unnecessary in 
most patients [36].  
 
There are few studies investigating the effect of diet therapy (figure 2, page 20) on 
intake, weight development and outcome after MUGI surgery. The methodological 
descriptions of oral nutritional therapy often described as dietary advice/dietary 
counselling are scares and comparison between studies difficult to perform. 
 
Nicklin et al performed an interesting study with the aim to define what kind of 
advice patients and their relatives would like to receive on dealing with the post-
operative symptoms associated with oesophagectomy and gastrectomy [117]. An 
updated version of a previously designed booklet with information to patients 
following oesophagectomy was developed, based on a literature review, a 
patient/relative focus group and experience from health care professionals’.  
The revised booklet includes sections about the operation (details of 
oesophagectomy and gastrectomy), eating and drinking (swallowing, appetite, meal 
times), possible problems (dumping, nausea, diarrhoea etc), lifestyle after surgery, 
healthy eating (food suggestions and recipes) and after recovery (resuming a 
normal diet). However, the usefulness of the booklet is not evaluated.  
 
Bozzetti [118] investigated the effects of nutritional support on postoperative 
complications in a meta-analysis of 1410 subjects who underwent major abdominal 
surgery for gastrointestinal cancer. Age of the patient, type of surgery and serum 
albumin had a significant association with the onset of postoperative complications. 
The risk of complications increased continuously with an increase in weight loss 
above 10%. The benefit of nutritional support (total parenteral nutrition, enteral 
nutrition, immune-enhancing enteral nutrition) compared to standard intravenous 
fluids was evident in all strata of their patient population but, it was more evident 
for the high risk group (pancreatic tumour, >75 year of age, low albumin levels) 
and for patients with severe weight loss.  
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AIMS OF THE STUDY 
 
 
The overall aim of this thesis was to study energy balance, body composition and 
functional capacity in patients on oral nutritional therapy after major upper 
gastrointestinal surgery.  
 
The following specific aims were addressed: 
 
Study A: 
• To evaluate the effects of 12 months oral nutritional therapy long time after 
TG, on body weight, body composition and components of energy 
metabolism. Also, to evaluate the components of the oral nutritional therapy, 
-individual dietary advice and oral nutritional supplements. (paper I) 
 
• To validate TEE measured by an activity monitor – the ActiReg® system, 
and a retrospective physical activity interview - “Hyrim Physical Activity 
Questionnaire” (HPAQmodified) using DLW as reference method long time 
after TG due to gastric cancer. Also, to investigate the ability of the methods 
to detect differences in TEE between baseline and 12 months follow up. 
(paper II) 
 
Study B: 
• To evaluate changes in body weight, body composition and body energy 
content, measured by DXA, during the first postoperative year after MUGI 
surgery in patients receiving nutritional therapy.  
Also, to describe the oral nutritional therapy and evaluate energy and 
macronutrient intake in relation to energy balance. (paper III) 
 
• To study changes in TBSMM and functional capacity before, six and twelve 
months after MUGI surgery. Also, to investigate the relation between 1) 
muscle mass and functional capacity (measured as exercise capacity), and 2) 
if changes in muscle mass are related to changes in functional capacity and 
3) if this relation may be influenced by energy balance. (paper IV) 
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OVERALL DESIGN AND METHODS 
 
This thesis is based of two studies in which the studies are presented in two papers 
each (table 2).  
 
Table 2: Overview of design in the two different studies.  
 Study A Study B 
Paper I  II III IV 
Design Prospective, non-randomized clinical trial 
 
Secondary analysis of a randomized clinical 
trial  
Participants 15 patients (5 women, 10 men) who had 
underwent TG due to gastric carcinoma more 
than 5 years ago. 
41 patients (14 women, 27 men) during the 
first postoperative year after MUGI surgery. 
Methods BW and height, 
Body composition 
by DXA, Dietary 
Intake by 4D FR, 
REE by indirect 
calorimetry,  
TEE by DLW 
BW and height, 
REE by indirect 
calorimetry,  
TEE by DLW, 
PAEE by Actireg 
and HPAQmodified 
BW and height, 
Body composition 
by DXA, Dietary 
Intake by 4D FR 
REE by indirect 
calorimetry 
BW and height, 
Body composition 
by DXA,  
Exercise capacity by 
treadmill 
 
Intervention Oral Nutritional 
therapy 
Oral Nutritional  
therapy 
Nutritional therapy Nutritional therapy 
Statistical analysis Descriptive statistics 
mean (SD), Students 
t-test for dependent 
samples, Wilcoxon 
signed rank test 
Descriptive statistics 
mean (SD), 95% CI, 
One-sample 
Kolmogorov- 
Smirnov test, 
Students t-test for 
dependent samples, 
Bland-Altman plot, 
Linear regression 
Descriptive statistics 
mean (SD), One-
sample Kolmogorov- 
Smirnov test, 
Students t-test for 
dependent and 
independent 
samples, ANOVA 
for repeated 
measures, Pearson 
product moment 
correlation 
coefficient, Fishers 
exact or Chi-square 
test 
Descriptive statistics 
mean (SD), One-
sample Kolmogorov- 
Smirnov test, 
Students t-test for 
dependent and 
independent 
samples, One-way 
ANOVA for several 
group comparisons, 
ANOVA for 
repeated measures, 
Pearson product 
moment correlation 
coefficient, Scatter 
dot plots, Linear 
regression, Fishers 
exact or Chi-square 
tests 
TG ; Total Gastrectomy, MUGI; Major Upper Gastrointestinal, BW;Body Weight, DXA;Dual energy X-ray 
Absorptiometry, 4D FR;4-Day Food Record, REE;Resting energy expenditure, TEE;Total Energy Expenditure, 
PAEE;Physical Activity Energy Expenditure, HPAQmodified; Hyrim Physical Activity Questionnaire. 
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STUDY POPULATIONS 
 
 
Study A. 
Long-time survivors (more than five years) after TG for gastric carcinoma, 
performed at the Sahlgrenska University Hospital, were invited to participate. They 
had to live at home and for logistical reasons live in the city of Gothenburg. They 
had to be without signs of recurrent cancer, dementia, severe illness, drug abuse 
and no major surgery performed or planned. Also, they had to show at least a 5% 
weight loss at inclusion as compared to their preoperative weight. The original 
intention was to include 25 patients, but only 18 long-term survivors could be 
identified from hospital records, of which 15 patients agreed to participate. Main 
reasons for this low patient availability at a reasonably large centre may be a mean 
high age at diagnosis combined with the poor prognosis. The study was carried out 
from May 1999 until May 2002. 
 
Study B.  
This is a secondary analysis of a previously reported study of postoperative 
nutritional therapy carried out from October 1995 until February 2000 at the 
Department of Surgery at the Sahlgrenska University Hospital. During this period 
126 consecutive patients were included in the study for resection of the 
oesophagus, stomach, or pancreas. Forty-six patients (36%) were excluded prior to 
randomization as a result of disseminated disease, thus 80 patients were included 
for follow-up and eligible for the present analysis [89]. The initial study was a 
randomized controlled trial to evaluate the effects of prolonged (3 months) 
postoperative nutritional therapy by enteral nutrition versus parenteral nutrition 
versus the effects of no artificial nutrition. Initial inclusion criteria were major 
resective surgical procedures in the upper gastrointestinal tract when curative 
resection for patients with malignant disease was deemed possible. Additional 
inclusion criteria in this analysis were available measurements of body composition 
by DXA preoperative and 12 months postoperative. All three study groups received 
individualised oral nutritional therapy during the first postoperative year, prescribed 
by a dietitian based on a standardized protocol. All patients were judged to be 
clinically free from recurrent disease. Postoperative changes in body weight, body 
composition and exercise capacity did not deviate between the 3 randomized study 
groups and there were no significant differences in total energy and protein intake 
between the groups over time. Survival, as well as mean hospital stay, did not differ 
significantly among the groups.  Hence, we merged the groups into one for the 
present analysis.   
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METHODS 
 
Body weight 
Pre-illness and preoperative body weight was collected from hospital records or by 
asking the patients. Body weight and height were measured at baseline and 
thereafter at month 1, 3, 6, and 12. BMI was calculated according to body weight 
(kg) divided by height squared (m2).  
 
Patients with a postoperative body weight loss >5% at 12 months were classified as 
weight losers and those who had lost <5% or gained weight were classified as 
weight stable (paper III, IV) 
 
Body composition 
Body composition was assessed with dual energy X-ray absorptiometry, DXA. 
Whole body DXA scans yield a 3-compartment model of fat, lean soft tissue, and 
bone mineral content for the whole body and also for specific regions of the body 
(i.e. arms, legs, trunk, and head). For body composition, data are commonly 
transformed to a classical 2-compartment model of fat (BF) and fat-free mass 
(FFM), where FFM is the sum of lean soft tissue and bone mineral content. DXA 
can also, using the sum of lean soft tissue in arms and legs (appendicular lean soft 
tissue), accurately determine skeletal muscle mass.  
 
Study A (paper I) 
DXA was performed at baseline and at 12 months using a Hologic QDR-2000 
scanner (Mediel AB, Gothenburg, Sweden). Whole body scans were obtained and 
analyzed using enhanced array whole body software version 5.73A. 
 
Study B (paper III, IV) 
DXA measurements were performed at baseline, 6 and 12 months postoperatively 
with a LUNAR DPX-L (Scanexport Medical, Helsingborg, Sweden) with software 
version 1.31 and with the extended analysis program for total body analysis 
(LUNAR Radiation, Madison, WI, USA). The LUNAR DPX-L scanner uses a 
constant potential X-ray source and a K-edge filter to achieve a congruent beam of 
stable dual-energy radiation. Whole body scans were performed at the scan speed 
suggested by the system for each subject. A quality assurance test was conducted 
on a daily basis, as recommended by the manufacturer. Precision errors on the 
scanner, as determined from double examinations in 10 healthy subjects, were 1.7% 
for body fat, 0.7 % for lean soft tissue and 1.9 % for bone mineral content.  
Total variation in appendicular lean soft tissue was not evaluated on this LUNAR-
machine, but based on duplicate DXA measurements in 30 subjects on a Lunar 
Prodigy in our laboratory a coefficient of variation of 2.7 % was found. 
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Body energy content  
Study B (paper III) 
Differences in whole body energy content during the 12 month study were 
calculated from the measurements of BF and FFM. DXA measures BF and FFM 
with high precision. The coefficient of variation in body energy content was 1.02% 
on duplicate DXA measurements in 30 subjects on a Lunar Prodigy in our 
laboratory.  
 
The energy density of BF is well established (9.4 Mcal/kg, or 39.4 MJ/kg) [77]. 
Since the energy density of FFM may be more variable we calculated it on an 
individual basis as follows;  
 
Body content of protein and glycogen = fat free mass- [total body water (73% of fat 
free mass) + soft tissue minerals (1.29% of total body water [78]) + bone mineral 
content].  
 
Energy content of protein and glycogen was calculated as 4.1 Mcal/kg (17 MJ/kg) 
[69].  
 
 
Skeletal muscle mass  
Study B (paper IV) 
Using DXA regional measurements, appendicular skeletal muscle mass (ASMM) 
was defined as the sum of lean soft tissue in arms and legs (ALST) according to 
Heymsfield [119]. Total body skeletal muscle  mass (TBSMM) was then calculated 
according to Kim et al [Model 1: 1.19 x appendicular lean soft tissue (kg) - 1.65)] 
[52]. 
 
Energy metabolism 
Total energy expenditure  
Study A 
TEE by DLW was measured over a period of 14 days. Patients came to the 
laboratory in the morning after voiding and a normal breakfast. Prior to dosing, a 
second voiding was collected for determination of background isotope enrichment. 
Patients were given a weighed mixture of DLW, corresponding to 0.05 g of 
deuterium oxide (2H2O) and 0.10 g of oxygen-18-water (H218O) per kilogram BW. 
The dose was flushed down the throat with a glass of tap water. Exact time of 
dosing was recorded, and the subjects were equipped with 30 screw-capped glass 
vials to be filled 8 and 12 h after dosing, and with the second voiding from day 2, 3, 
4, 5, 10, 13, 14, 15, respectively. Exact voiding time was registered, and the urine 
samples were stored in freezer before delivery to the laboratory. Urine samples 
were analysed in triplicates on a Finnigan MAT Delta Plus Isotope-Ratio Mass 
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Spectrometer (ThermoFinnigan, Uppsala, Sweden) with a variation (SD) of 0.40 
delta per mill for deuterium and 0.16 for oxygen. TEE from DLW was calculated 
by the multipoint method, using linear regression from the difference between 
elimination constants of deuterium and oxygen-18, with the assumptions for 
fractionation as suggested by IAEA [120]. The energy equivalence of the CO2 
excreted was calculated from estimated food quotient from a 4D FR [121].  
 
Resting energy expenditure 
REE was measured at baseline and at 12 months in study A and at baseline, 1, 3, 6 
and 12 months in study B. Measurements were performed in the morning after an 
overnight fast by open-air circuit indirect calorimetry (Deltatrac metabolic monitor, 
Datex, Helsinki, Finland). Patients rested supine for 20-30 minutes in a quiet room 
with a temperature of 20-22°C before the start of the measurements. REE was then 
measured for approximately 30 minutes by open-air circuit indirect calorimetri with 
a ventilated hood. Metabolic rate was calculated from the oxygen consumption and 
carbon dioxide production using the Weir equation [122] and expressed per 24 h. 
(paper I, II, III).  
 
Physical activity energy expenditure  
Study A (paper II) 
In the late 90s, when study A was planned, available motion sensor methods to 
assess physical activity energy were few [123] and DLW was just recognized as the 
gold standard for the validation of field methods [124]. In cooperation with the 
University of Oslo, we had the opportunity to use and validate a new promising 
motion sensor, the ActiReg® [125]. Also the HPAQ was developed in Oslo and had 
been validated against ActiReg® [126]. At that time I thought it would be 
interesting to try the interview technique in a clinical situation and with the 
opportunity to validate it against DLW. 
 
ActiReg® 
The ActiReg® system (PreMed AS, Oslo) uses combined measures of body position 
and motion to calculate energy expenditure and express physical activity [125]. It 
consists of two components, an activity monitor (ActiReg®) and a dedicated 
software (Acticalc®) for processing and presenting data and calculating energy 
expenditure. The device has two body position sensors (tilt switches) and two 
motion sensors connected by cables to a battery-operated storage unit. Each pair of 
one tilt switch and one motion switch is secured in a plastic bracket. One bracket is 
attached to the chest (sternum) and the other is fastened on the front of the right 
thigh. The tilt switches go from on to off when they deviate more than 45° from the 
vertical position. The motion sensors operate according to the all or none principle; 
they register either motion or no motion. The state of the body position and motion 
sensors is checked every 1 s. The sensors discriminate between the body positions 
sitting, standing, bending forward and lying supine and between the four states of 
no motion, motion on either chest or thigh sensor, or both. This gives the possibility 
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of 16 different combinations, with ActiReg® codes from 0 to 15. After a recording 
period, the stored data are transferred to a personal computer. ActiCalc® converts 
the data into information about body motion, body position and position changes 
for each minute. Every minute is assigned the most frequent registered body 
position. The pattern of the sixty codes recorded provides information about the 
physical activity (PA) level. ActiCalc® uses the activity factor to calculate an 
activity factor (AF). AF is then used to categorize PA into three levels: very low 
PA, low PA and moderate to high PA.  
The different levels of PA together with the body position is given a metabolic 
constant taken from WHO’s published reference values [127]. The metabolic 
constants are then multiplied with calculated or measured REE. The second 
calculation step takes the number of position changes into account by using the 
algorithm given in figure 3.  
 
 
 
Figure 3. The calculation procedure for energy expenditure (EE) based on ActiReg®. 
 
 
Patients were instructed to wear ActiReg® during 3 consecutive days within the 14-
days DLW schedule, except during water activities (bathing/showering). They were 
carefully instructed on how to attach the sensors to their body. Measured REE was 
used for calculation of TEE. 
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The physical activity interview –HPAQmodified 
The physical activity interview was conducted using a modified version of Hyrim 
Physical Activity Questionnaire (HPAQmodified) [128]. HPAQ has been developed to 
capture total energy expenditure including occupational time, transportation, 
recreation, leisure time and household activities. The modified version used in this 
study had no questions about work related time since the majority of patients 
(13/15) were retired. Instead the questionnaire focused more on low activity related 
activities, such as personal care, meal time and sleep. HPAQ is a retrospective 
interview covering the last 7 days and the interview takes about 20 minutes. It was 
performed at baseline and at 12 months, on the last day of the 14-days DLW 
schedule. The same interviewer conducted all interviews. Ainsworth’s 
Compendium of Physical Activities [67] was used to calculate energy expenditure 
from the activities identified in the questionnaire and measured REE was used to 
calculate TEE. Intensity of sport-related activities were classified according to 
Borg’s scale [129]. Time not reported was taken to be 1.5 METs corresponding to 
activities performed while sitting down and low intensity activities such as social or 
cultural leisure time activities. Calculations of TEE from the activity data were then 
performed in Excel®. 
 
Dietary intake 
Study A and B (paper I, III) 
At baseline and at month 1, 3, 6 and 12, the patients completed a 4-day food record 
(4D FR). They were instructed to continue their normal eating habits and keep a 
complete and accurate record for 4 consecutive days, 3 weekdays and 1 weekend 
day (study B included 2 weekdays and 2 weekend days). Instructions were made to 
express all quantities in common household measures and to provide a complete 
description of the food items and also of the preparation and cooking. A detailed 
check-up was then made for incomplete recording, type of food and portion size 
with the aid of a portion-guide for estimating consumed amounts of food [130]. In 
study A check-ups were mostly performed in the patients own home except at 
baseline and 12 months were it was done at the out-patient clinic. In study B check-
ups were always done at the out-patient clinic. The content of energy and nutrients 
were calculated using the software KOSTSVAR (Aivo, Stockholm, Sweden). The 
nutrient database used was the Swedish National Food Composition Tables [131]. 
  
On an individual level these data were used to design the individual oral nutritional 
therapy since it, besides energy and protein intake, described the type of food items 
used and the meal pattern.  
 
Energy balance 
Study B (paper IV) 
Energy balance was defined as the difference in body energy content (see Body 
energy content page 39) at two different points in time, and expressed in kcal/day 
by dividing the absolute difference by the time interval between measurements. 
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Functional capacity  
Study B (paper IV) 
Functional capacity was evaluated by a treadmill test. The test started with the 
patient standing on the treadmill (Cardionics, Bandhagen, Sweden) for 1 min and 
thereafter walking at 1.5 km/h for 2 min without elevation. The test program then 
continued with walking at 1.5 km/h at 12% elevation for 1 min; thereafter, speed 
was increased by 0.1 km/h every 10th second until the patient chose to finish the 
test. The speed at which the patients finished the test was defined as maximal 
exercise power. The maximal mechanical power (W) at exercise was calculated by 
the software provided by the manufacturer (Medical Graphics Corp. St Paul, 
Minnesota, US) accounting for body weight, walking speed, and the elevation angle 
of the treadmill.  
 
Oral Nutritional Therapy 
Study A 
Based on information from 4D FR and calculated energy and protein requirements 
all patients received individualized dietary counselling by a dietitian once a month 
in the patients’ home and/or out-patient clinic or over the telephone. Energy intake 
was targeted to 40 kcal/kg body weight and day according to the Swedish hospital 
recommendation for weight gain [132]. Dietary advice were based on the energy 
and protein rich diet [132]. In this diet, preferential use of  energy dense food items 
and the enrichment of food dishes by the addition  of fat in the form of cream, sour 
cream, margarine or butter, oil and cheese is recommended to increase energy 
density (40-50% of total energy intake is from fat).  Protein should contribute 18-
20% of the total energy intake. The portion size is recommended to be half of a 
normal meal size at a given energy level and a compensatory higher meal 
frequency (6-8 meal/day) is recommended. 
 
 If energy and/or protein intake from food was considered insufficient and further 
diet modifications seemed difficult to implement, ONS were used depending on 
both estimated supplement needs and patient preference. Either energy- (150 kcal 
and 6 g protein/100 ml, Nutridrink®, Nutricia AB, Stockholm, Sweden) or a 
protein-rich supplement (100 kcal and 10 g protein/100 ml, Fortimel®, Nutricia, 
Stockholm, Sweden) was recommended depending on calculated requirements and 
reported intake from the 4D FR. The supplements were provided free of charge 
during the study. If the patients had problems with the intake of the first choice 
supplements, a clear juice-based liquid supplement (125 kcal and 4 g protein/100 
ml, Ensini®, Nutricia, Stockholm, Sweden) and/or a supplement intended to use as 
a hot soup (100 kcal and 4 g protein/100 ml Ensure®, Abbot Nutrition, Stockholm, 
Sweden) and/or a energy powder supplement (380 kcal/100 g Maxijoule Super®, 
Nutricia, Stockholm, Sweden) were recommended depending on both estimated 
supplement needs and patient preference.  
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The dietitian checked compliance with the dietary advice and use of ONS monthly 
at the regular follow up. 4D FR, current weight, and questions about general health 
condition, with focus on post-absorptive symptoms, were used to monitor and re-
assess oral nutritional therapy and nutritional status. After the study the delivered 
amount of ONS was compared with the consumed amount according to the 4D FR 
as an additional indicator of compliance.  
 
Study B 
Before and after discharge from the hospital, all patients received individualized 
dietary counselling by a dietitian. The dietary counselling was based on a standard 
protocol (table 3), but individualized based on reported intake of energy and 
nutrients, use of different food items and meal pattern from the 4D FR and patients’ 
food preferences. If nutrition related surgical symptoms were present following 
advice were given; due to early satiety, low appetite and food intake related pain 
(odynophagia) a reduced portion size with a compensatory higher meal frequency 
was recommended. In order to prevent epigastric fullness and to optimize the 
energy and nutrient intake at the main meals, it was recommended to eat slowly and 
drink between meals.  If at risk of sub-/ileus patients were advised to eat slowly and 
chew carefully and avoid foods with stringy fibres or risk of swallowing whole 
pieces (table 3). Energy enrichment of food dishes and use of energy dense food 
were recommended to prevent or treat unintentional weight loss. A high fat intake 
was recommended despite the possible presence of fat malabsorption and instead 
supplementation with pancreatic enzymes was used. Dumping syndrome was 
nutritionally treated with a diet low in single carbohydrates (hypoosmolar) diet 
[133]. The dietitian checked compliance with the dietary advice and use of ONS 
monthly at the regular follow up. 4D FR, current weight, and questions about 
general health condition, with focus on post-absorptive symptoms, were used to 
monitor and re-assess oral nutritional therapy and nutritional status 
 
Energy intake was targeted to 35-40 kcal/kg body weight and day and protein 
intake was targeted to 1.5-2.0 g/kg body weight and day.  
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Table 3. Standard protocol for oral nutritional therapy. 
 
Counselling Diet Dietary advice 
Dietary counselling I 
 
POD 4-6 
In hospital 
Liquid diet  Add between-meal snacks to the 
regular meals (a total of 5-6 meals 
a day) 
Use energy and protein rich  ONS 
as first choice for between-meal 
snack 
Chew carefully and eat slowly 
Drink between meals not with 
meals 
Dietary counselling II 
 
POD 5-7 
In hospital 
Postoperative dieta ½ portion 
 
Prescription of ONS 
Choice of energy dense food items 
and enrichment of food dishes 
with addition of fat as cream, 
butter, margarine, cheese, sour 
cream, and oil. 
If necessary adjust dose of 
pancreatic enzyme substitution 
Multivitamin tablet 
Individual dietary advice was 
adjusted to individual food habits 
and taste preferences 
Dietary counselling III-VI 
 
During the first3-4  weeks after 
discharge 
Telephone call once a week 
Postoperative dieta Check of body weight, food and 
fluid intake, vitamin supplements 
and ONS. Dietary advice were 
repeated or adjusted as needed  
Dietary counselling VII-XI 
1,3,6 and 12  months after surgery 
Out-patient clinic  
If needed additional consultation 
from dietitian was offered. 
Postoperative dieta Check of body weight, food and 
fluid intake, vitamin supplements 
and ONS (4-day food record). 
Dietary advice were repeated or 
adjusted as needed 
aPrinciples of the Postoperative diet 
Due to the risk for sub-/ileus, patients are recommended to avoid stringy meat and foods, rice, pasta, fruit peel 
etc. In hospital the postoperative diet is served as ½ portions due to the gastric restriction. 
Avoid Choose 
Stringy meat Minced meat, fish, sausages, eggs,  
Rice, pasta Potatoes/ mashed potatoes 
Fresh vegetables Cooked vegetables but avoidb 
Fresh fruits Cooked fruits but avoidb 
Fresh baked bread, white soft bread Bread older than one day, crisp bread, bread 
baked with coarse flour without whole kernels  
b Stringy vegetables –asparagus, broccoli stalk, tomato peel, peas, corn, beans, lentils, mushrooms, stripes of 
onion, stringy fruit like pineapple and citrus, fruit peel, almond, nuts, dried coco flakes, dried fruit 
POD, postoperative day; ONS, oral nutritional supplement. 
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Statistics 
Descriptive values are presented as mean and standard deviation (SD). Data were 
tested for deviation from normal distribution by one-sample Kolmogorov-Smirnov 
test (paper II, III, IV). For normally distributed variables, Students t test for 
dependent and independent samples was applied to analyse the difference between 
two groups or between two points in time (paper I, II, III, IV). For skewed data, 
Wilcoxon signed ranks test were used in the analysis on food groups (paper I). 
 
Linear regression was used in the analysis of ActiReg® measurements to determine 
the association of different body positions and intensity of PA to the dependent 
variable PALDLW. Precision of the methods, estimated as the coefficient of variation 
(CV%) from the repeated measurements was calculated according to the formula 
(√∑(x1-x2)2/2n)/Χ*100. The differences DLW - ActiReg® and DLW - HPAQmodified 
were examined against the reference method DLW in a modified Bland-Altman 
plot (paper II). 
 
Comparisons between more than two group means were analysed by one-way 
ANOVA. Statistical analyses of change in a variable over time (>2 measures) were 
tested with analysis of variance (ANOVA) for repeated measures, with Bonferroni 
correction for multiple comparisons (paper III and IV).  
 
To investigate relationship between variables Pearson product-moment correlation 
coefficient was used (paper III and IV), together with scatter-dot plots and linear 
regression (paper IV).  
 
Nominal data were tested by Fishers’s exact or Chi-square tests where appropriate 
(paper III and IV). 
 
A p value less than 0.05 was considered significant (paper I, II, III, IV). 
 
Calculations in paper I and II were made in SPSS for Windows version 11.5 and 
version 16.0 in paper III and IV (SPSS Inc., Chicago, Ill, USA). 
 
 47
RESULTS 
 
 
Subjects 
Study A 
Of 18 patients identified from hospital records 15 were included. Two patients 
dropped of from the study due to illness in the family and problems to adhere to 
study protocol, respectively. Patient characteristics and time since surgery are given 
in table 4. Compared to pre-illness weight the group had lost a mean of 11% (n=13) 
at study start but one patient had actually resumed his pre-illness weight. Compared 
to preoperative weight, the group had lost a mean of 6 % but weight loss was less 
than 5% in 5 patients. One third of the patients had a BMI less than 22 and another 
third above 25. 
 
 
Table 4. Subject characteristics at study start.  
 
 Age  
study 
start 
Years  
since 
TG 
BMI 
preillness 
BMI 
preop 
BMI 
study 
start 
Weight change 
from pre-illness to 
study start (%) 
Weight change 
from preop to 
study start (%) 
Women  82 7 23.9 23.9 22.0 -8.0 -8.0 
(n=5) 65 8 29.6 29.6 27.5 -7.1 -6.8 
 71 10 26.2 24.0 24.5 -6.5 1.9 
 63 8 28.2 28.0 26.5 -5.8 -5.1 
 68 12 23.2 20.2 18.4 -20.7 -8.9 
        
Men  74 7 25.7 22.6 21.5 -16.1 -4.9 
(n=10) 76 9 20.2 19.3 16.0 -20.7 -17.0 
 79 9 27.8 25.9 24.5 -11.8 -5.3 
 63 10 NA 26.3 20.5 NA -22.1 
 64 17 26.7 26.4 25.5 -4.8 -3.5 
 55 9 22.5 21.1 19.2 -14.6 -9.0 
 64 15 23.3 22.8 22.4 -4.1 -1.7 
 61 11 24.7 21.7 25.2 2.0 16.2 
 74 10 NA 24.1 25.1 NA 4.1 
 64 9 30.5 29.3 24.6 -19.3 -15.9 
        
Mean 
(n=15) 
68 (7) 10 (2) 25.6 
(3.0) 
24.3 
(3.2) 
22.9 
(3.2) 
-10.6 (7.2) -5.7 (9.2) 
NA=not available, SD in paranthesis 
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Study B 
In the initial study 80 patients were finally included and randomized. Of these, only 
4% were lost due to missing DXA measurements. However, 31% of the patients 
were lost due to recurrent disease or death, and 14% were lost to follow up or 
withdrew their consent. The inclusion procedure and type of gastrointestinal 
resection is depicted in the flow chart in figure 4.  
 
No differences were found between included and excluded patients in the 
preoperative variables. Preoperative patient characteristics is presented in table 5. 
 
Table 5. Subject characteristics at study start. BMI and weight change before illness and 
preoperative to total gastrectomy (TG) (SD in paranthesis). 
 
 Age  
study start 
BMI 
preillness 
BMI 
preop 
Weight change 
Preop (%) 
Weight change 
Preop (kg) 
Women (n=14) 59 (11) 26.0 (2.6) 23.9 (1.7) -7.7 (7.7) 5.5 (5.9) 
Men (n=27) 60 (14) 25.7 (2.4) 23.5 (3.0) -8.3 (8.5) 6.7 (7.0) 
Mean (n=41) 60 (13) 25.8 (2.4) 23.6 (2.6) -8.1 (8.2) 6.3 (6.6) 
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Figure 4: Flow chart describing the participants through each stage in study B. 
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Body weight 
Study A 
After the first month with dietary counselling there was a trend of weight gain. 
However, at 12 months no average changes in weight were found. However, weight 
development was heterogeneous, and six patients who had no signs of disease or 
health related problems gained weight whereas 5 patients who had various self-
reported health problems lost weight, although not significantly. At inclusion 2 
patients had a BMI >25 and although they at the beginning of the study claimed a 
wish to gain weight they later on expressed satisfaction with their current weight 
(table 6).  
 
 
Table 6. BMI during the study year, total group and sub groups.  
 
 n Baseline 1 month 3 months 6 months 12 months 
Total group 13 23.1 (3.2) 23.4 (3.2)** 23.3 (3.1) 23.1 (2.9) 22.9 (3.0) 
Weight gaining  6 22.7 (2.2) 23.1 (2.3) 22.9 (2.0) 23.1 (1.9) 23.4 (2.1)* 
Weight losing  5 22.6 (4.7) 22.9 (4.5) 23.0 (4.6)* 22.3 (4.2) 21.4 (4.0) 
BMI>25 2 25.3 (0.2) 25.4 (0.6) 25.1 (0.5) 25.3 (0.1) 25.1 (0.2) 
Standard deviation in parenthesis. * p< 0.05  **p=0.06-0.10 
 
 
Study B 
There was a significant reduction in average body weight during the first 
postoperative year, most of which occurred during the first postoperative month 
(3.9 (3.9) kg or 5.4%). This weight loss persisted throughout the first postoperative 
year, resulting in a total average body weight loss of 4.1 (6.9) kg or 6.9 (10.8)% 
(figure 2). There were no significant differences in body weight change between 
genders. There was a negative correlation between preoperative body weight loss 
and postoperative development of body weight. However, no relationship between 
preoperative BMI and postoperative development of body weight was found. 
 
Although average body weight decreased during the study, 29% of the patients 
(men/women, 9/3) remained weight stable. More than 2 out of 3 (71 %) of the 
patients lost weight during the 12 months study (defined as a body weight loss of 
5% or more -the weight losing group), and approximately 1 out of 3 (29 %) 
remained weight stable (-the weight stable group). Although the weight losing and 
weight stable groups did not differ in absolute body weight during the 12 months 
study, they did differ in development of body weight (figure 5). There were no 
significant gender differences between the weight losing and weight gaining 
groups. We found no preoperative differences between weight losing and weight 
stable patients in BMI, REE, energy intake/REE-ratio, reported energy intake/kg 
body weight, reported protein intake/kg body weight or length of artificial 
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nutritional support.  However, the weight stable group reported a higher 
preoperative weight loss (13.3 (9.4)% vs 6.0 (6.7)%, p<0.01).  
 
 
 
 
Figure 5. Development of body weight for the whole group (n=38) and for weight losing 
(WL, n=26) and weight stable (WS, n=12) groups during the first year after major upper 
gastrointestinal surgery.  Different letters indicate significant difference between the 
various time points. Differences in development of body weight between the weight losing 
group and the weight stable group between different time points are indicated by *p< 0.05 
and ** p<0.01, ns=not significant. ●Whole group, ▼WL, ▲WS 
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Body composition 
Study A 
Body composition showed no average significant changes in FFM or BF at 12 
months. In the group of 6 patients who remained healthy during the study year 
there were a significant higher content of BF at 12 months while FFM were 
unchanged. 
 
Study B 
Compared to a Swedish reference material [134] both men and women had lower 
BMI, BFI and FFMI at all time points, though for women the difference in FFMI 
was not significant at 6 and 12 months postoperatively.  
 
Most of the body mass lost was BF and at 12 months on average 26 % of 
preoperative BF stores were lost. No significant change in FFM was found and 
there were no significant differences between genders in body composition 
changes. (table 7) 
 
Table 7.  Body composition assessed by DXA (dual energy x-ray absorptiometry) 
preoperative (preop), six (6m) and twelve months (12m) after major upper gastrointestinal 
surgery. No significant differences in development of body weight, body fat and fat free 
mass were found between men and women.  
 
 Women 
n=13  
Men 
n=25  
Total 
n=38  
 mean (sd) mean (sd) mean (sd) 
FFMpreop (kg) 40.3 (3.6) ∆∆∆ 56.5 (5.8) 51.0 (9.3) 
FFM6m (kg) 40.4 (3.9) ∆∆∆ 55.4 (4.8) (*) 50.3 (8.5) 
FFM12m (kg) 40.5 (3.6) ∆∆∆ 56.4 (5.5) 50.9 (9.1) 
BFpreop (kg) 22.0 (4.4) ∆∆ 16.8 (6.1) 18.6 (6.1) 
BF6m (kg) 17.1 (6.3)* (∆) 13.1 (6.8) ** 14.4 (6.8) *** 
BF12m (kg) 16.0 (7.1)(*) (∆) 12.9 (6.3) ** 13.9 (6.7) *** 
Fatnesspreop (%)  35.2 (5.1) ∆∆∆ 22.4 (5.7) 26.7 (8.2) 
Fatness6m (%) 29.1 (7.3)*  ∆∆∆ 18.3 (7.3) ** 22.0 (8.9) *** 
Fatness12m (%)  27.3 (8.7)* ∆∆∆ 17.9 (6.9) ** 21.2 (8.7) *** 
FFM, fat free mass; BF, body fat; SD, standard deviation. (*) p>0.05<0.10 vs preop, * p<0.05 vs preop, ** p<0.01vs 
preop, ***p<0.001 vs preop, (∆) p>0.05>0.10 vs men,  ∆ p<0.05 vs men,  ∆∆ p<0.01 vs men, ∆∆∆ p<0.001vs men 
 
The weight stable group showed no significant change in BF but a gain in FFM 
between preoperative and twelve months measures. Among the weight-losing 
patients a major part of the weight loss was BF although loss of FFM was also 
significant. 
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Energy metabolism 
Total energy expenditure 
Study A 
Total energy expenditure from DLW was 2430 (540) kcal/day at inclusion. This 
corresponds to 37 (4) kcal/kg/d, range 31-44 kcal/kg/d. After the 12 months 
intervention no change in average total energy expenditure was found. 
 
Resting energy expenditure 
Study A 
The mean REE at inclusion (n=15) and the end of the study (n=13) were 1470 
(260) and 1460 (250) kcal/day, corresponding to 22 (3) and 22 (3) kcal/kg/d, 
respectively. REE ranged between 17-29 kcal/kg/d and day at inclusion. 
 
Study B 
Mean REE preoperatively (n=41) and at the end of the study (n=39) were 1550 
(190) kcal/day and 1550 (220) kcal/day, corresponding to 22 (2) and 24 (3) 
kcal/kg/d. REE ranged between 18-29 kcal/kg/d preoperatively, and 18-31 
kcal/kg/d 1 year after surgery.  
 
Physical activity energy expenditure 
Study A (paper II) 
The physical activity level measured by DLW and indirect calorimetry varied 
within a wide range, 1.30-2.12. Five patients had a PAL <1.50 and 6 patients >1.70.  
 
TEE values by both ActiReg® and HPAQmodified were highly correlated to TEE 
values by DLW (r=0.89, p<0.001 and r=0.81, p<0.001). However, both methods 
underestimated (180 (254) kcal/day, p<0.05 and 130 (326) kcal/day, ns, 
respectively) although only significant for ActiReg®. Differences were more 
pronounced at higher levels of activity, and there was a systematic underestimation 
in individuals with PALDLW > 1.65 for both ActiReg® and HPAQmodified (figure 6).  
From the measurements with Actireg® it was found that the group with low PAL 
(<1.65) spent significantly more time in the supine positions compared to the group 
with high PAL (>1.65).  
 
In a multivariate analysis using the time spent in different body positions and 
activity levels as predictors only activity level=low remained a significant predictor 
for PAL. 
 
Repeated measurements of TEE (paper II) 
At 12 months TEEDLW was unchanged, mean difference was 25 (166) kcal/day 
compared to baseline. Corresponding Actireg® measurements were -23 (118) 
kcal/day and HPAQmodified 153 (379) kcal/day and neither of them deviated from 
TEEDLW. The 95% confidence interval of the difference between baseline and 12 
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months was -123 to 71 kcal/day from DLW, -62 to 108 kcal/day from ActiReg® 
and -382 to 76 kcal/day for HPAQmodified.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Differences between (a) PALAR and PALDLW are plotted against PALDLW and (b) 
PALHPAQmodified and PALDLW are plotted against PALDLW. Limits of agreement of the mean 
difference (± 2 SD) are indicated by the dotted lines. For both comparisons the differences 
are more pronounced at higher levels of PALDLW, as illustrated by the negative slope of the 
regression line (r= -0.816, p<0.05 and r= -0.737, p<0.05 for (a) and (b) respectively. 
 
 
Energy balance 
Study B (paper III and IV) 
During the first postoperative year, patients lost on average 44.2 (55.7) MCal 
(p<0.001) of their total body energy content, corresponding to 20 % of their total 
body energy content, with no significant difference between men and women. The 
group of weight losing patients lost 68.8 (38.6) MCal (p<0.001), corresponding to 
29 %, whereas the small group of weight stable patients increased marginally their 
energy stores by 15.1 (13.1) MCal, although this was not significantly different 
from zero. However, the changes in body energy content between the two groups 
differed significantly (p<0.001) (table 7).  
 
Expressed on a daily basis, the energy deficit during the first 6 months after surgery 
was 210 (260) kcal/day, whereas during the following 6 months energy balance 
was nearly achieved (-20 (150) kcal /day). Mean energy deficit during the entire 12 
months was 120 (150) kcal/day. The weight-losing group lost on average an 
equivalent of 190 (110) kcal/day during the entire study and at 6 months this loss 
was 340 (170) kcal/day with no significant differences between men and women. 
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Table 8. Energy balance in the included patients and also in weight losing (WL) and weight 
stable (WS) groups, respectively. No significant differences in energy balance were found 
between men and women.  
 
 
 
(men/women) 
Total 
n=38 
(25/13) 
WL 
n=26 
(15/11) 
WS 
n=12 
(9/3) 
Total Energy balance (mcal) mean (sem) mean (sem) mean (sem) 
Preop to six months postop -39.2 (7.8)*** -61.9 (6.2)*** ∆∆∆ 10.0 (11.4) 
Six months postop to 12 months postop -4.4 (4.4) -8.9 (5.4) 5.100 (7.5) 
Preop to 12 months postop -43.6 (9.3)*** -70.8 (7.7)*** ∆∆∆ 15.1 (13.1) 
Repeated measures analysed with ANOVA and adjusted for pairwise comparisons by Bonferroni. * p<0.05 vs preop, 
***p<0.001 vs preop. Differences between WL and WS analysed with unpaired Students t-test (∆) p>0.05<0.10 vs 
WS,  ∆ p<0.05 vs WS, ∆∆∆ p<0.001vs WS. Sem; standard error of the mean. 
 
 
Including energy balance as a predictor in a multivariate analysis between changes 
in total body skeletal muscle mass and changes in exercise capacity did not affect 
the slope of the line or increased the degree of explanation.  However, the weight 
losing group who was in a negative energy balance had a significant higher 
proportion of patients who lost skeletal muscle mass compared to the weight stable 
group (i.e. in energy balance). This was also reflected in exercise capacity with a 
significant higher proportion of patients from the weight losing group showing a 
reduction in exercise capacity compared to patients in the weight stable group. 
 
Calculated on the weight losing individuals the energy density of the lost body 
mass during the entire study was 8.3 (2.0) Mcal/kg body weight and the average 
body fat content of the weight loss was 87%. There were no significant differences 
between the energy density of lost body mass, and hence its’ content of BF, 
between men and women  
 
Dietary intake 
Study A 
At baseline all but 2 patients ate 6-8 meals per day as previously recommended. 
Several patients could not increase the total amount of food eaten due to symptoms 
commonly seen in TG patients like poor appetite, postprandial symptoms and early 
satiety. For many patients further diet modifications seemed difficult to implement, 
as they followed earlier diet recommendations. Mean energy density was 0.97 
kcal/g.  Supplemental ONS were prescribed to complement existing food intake in 
a majority of patients. However, mean meal frequency did not increase nor did the 
mean intake of energy- and protein, instead it seems like ONS replaced or 
suppressed ordinary food intake.  
 
On a group level the 4D FR underestimated energy intake slightly but this was not 
significant. However, a Bland-Altman plot revealed a large spread in individual 
values of differences between energy intake and total energy expenditure (figure 7). 
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Figure 7. Bland-Altman plots: the difference between EI and TEE plotted against the mean 
of EI and TEE at (a) baseline and at (b) 12 months. —— Mean, ------ plus or minus two SD. 
 
 
Study B (paper III) 
Reported energy intake (kcal/kg/d), energy intake/REE or energy density was not 
predictive of changes in body weight at any time point.  
 
Skeletal muscle mass 
Study B (paper IV) 
Preoperatively 13 out of 27 men (48%) and 1 out of 14 women (7%) were 
classified as sarcopenic [135]. 
 
Average TBSMM decreased significantly at 6 months postoperative but this loss 
was regained 6 months later. Changes in body weight were significantly associated 
with changes in TBSMM, but only for men when analysed by subgroups. Weight 
losers lost TBSMM during the first year as opposed to weight stable group. 
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Functional capacity 
Study B (paper IV) 
Although there was a reduction in exercise capacity at 6 months, no change from 
preoperative values was evident at 12 months postoperatively. Analyzed by 
subgroups it was found that men showed a trend to reduction and weight losers 
reduced their exercise capacity at 6 months but exercise capacity was restored in 
both groups at 12 months postoperatively.  
 
TBSMM was related to exercise capacity at all time points, and in both genders, 
and for weight losers and weight stable (table 8). Changes in TBSMM predicted 
changes in exercise capacity and this applied to men, women and the weight stable 
group but not in the weight losing group (figure 8). Changes in body weight 
predicted changes in exercise capacity but analyzed by subgroups this applied only 
for men.  
 
 
Table 9. Correlations between total body skeletal muscle mass (TBSMM) according to Kim 
(5) and exercise capacity at all times and in weight losing and weight stable and in both 
genders. 
 
Correlation coefficient 
and significant level 
TBSMMpre-Exercise 
capacitypre (W)  
TBSMM6m- Exercise 
capacity6m (W) 
TBSMM12m- Exercise 
capacity12m (W) 
Total 0,70*** 0,69*** 0,61*** 
Weight losers 0,74*** 0,69* 0,61** 
Weight stable 0,60* 0,70* 0,59(*) 
Men 0,85*** 0,81*** 0,71*** 
Women 0,66* 0,57* 0,59* 
 
(*)
 borderline significant p=0.05-0.10, *p<0.05, **p<0.01, ***p<0.001 
 
 
At the time of inclusion, both men and women in our study had lower exercise 
capacity compared to a Swedish reference population of healthy middle aged 
individuals (age 60-74) measured with the same protocol on the same treadmill 
[136]. 
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a) b) 
 
Figure 8. Correlations between change in exercise capacity during the first postoperative 
year and a) change in total body skeletal muscle mass (TBSMM); whole group n=36 r=0.58, 
p<0.001, men n=23 r=0.57, p<0.01, women n=13 r=0.62, p<0.05) and b) change in TBSMM; 
WL n=26 r=0.29 p=0.15, WS n=10 r=0.80 p<0.01. 
 
Additional data analysis in Study A 
From available hospital records the weight development preoperatively to one year 
after surgery (range 4 months to 1½ year) were identified and patients were 
classified as weight stable or weight losing in accordance with study B. Four 
patients (29%) were classified as WS and 10 (71%) patients were classified as WL.  
 
Preoperative weight change in the WS group was -8.3 (4.6) % and -3.8 (4.4) % in 
the WL group, p=0.13.  
 
On average 10 years after surgery 8/10 patients were still classified as weight 
losing whereas 3/4 were still weight stable (weight development from preoperative 
weight to weight at inclusion of study A). Long-term weight development, on 
average 10 years after surgery, in the weight stable group was 1.1 (10.2) kg (range -
5.3 to 16.2 kg) and in the weight losing group -9.2 (7.5) kg (range -22.1 to 4.1 kg), 
p=0.06.   
 
Weight stable patients had at the time for inclusion in study A a significantly higher 
FFMI (18.6 (0.7) vs 15.8 (2.0) kg/m2, p=0.02) and appendicular skeletal muscle 
mass index (7.1 (0.7) vs 5.8 (1.0) kg/m2, p=0.045) although there were no 
difference in weight (75.3 (3.0) vs 62.4 (14.0) kg, p=0.10. The weight stable group 
had also a significant higher exercise capacity as compared to weight losing (145 
(35) vs 87 (28) watt, p=0.006). Two of the 4 weight stable patients were classified 
as sarcopenic, whereas 8 patients in the weight losing group were classified as 
sarcopenic (p=0.52). 
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On average 10 years after surgery 7 out of 10 men (70%) and 3 out of 5 women 
(60%) were classified as sarcopenic according to reference values defined as >2 SD 
below the appendicular skeletal muscle mass index of a young reference population 
[135].  
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DISCUSSION 
 
 
The background to study A was the findings from a previously reported study of 
long-term survivors after total gastrectomy, at the Department of Surgery, 
Sahlgrenska Hospital [109]. This was a longitudinal study 5 to 8 years after surgery 
assessing weight and body composition changes. A loss of weight, greater than 
expected due to age, was found and also a significant loss of FFM. Oral nutritional 
therapy prescribed by a dietitian had been ended 5 years after surgery and the 
significance of nutritional surveillance in the long-term after TG was brought up. 
Thus, the overall aim of study A was to initiate oral nutritional therapy in a group 
of patients long time after TG, and evaluate its effects on body weight and body 
composition.  
 
In the late 90s, at the time when study A was planned, little was known about 
physical activity energy expenditure in disease and also the applicability of 
different methods to measure physical activity in the home environment. We had 
the opportunity to use the DLW method, but since it is a very expensive method 
that requires advanced technical equipment and skills it is not applicable in routine 
care. Therefore, we also examined the validity and usability of simpler devices, 
such as ActiReg® and HPAQmodified. 
 
In Study B we investigated development of body weight and body composition 
during the first year after surgery. As in study A, body composition was measured 
with DXA and since the time when both these studies were originally designed, the 
knowledge on how to use DXA body composition measurements for calculations of 
body energy content and skeletal muscle mass had evolved. This made it possible 
to quantify energy balance, assess muscle mass and investigate the relationship 
between muscle mass and functional capacity. 
   
Since we had revealed a lack of details in the method descriptions for oral 
nutritional therapy in the literature, one specific aim in both studies were to 
describe the oral nutritional therapy in detail.  
 
Methodological considerations 
 
Subjects 
The common feature of all study patients was that they all had undergone major 
upper gastrointestinal surgery. As patients were included consecutively they 
naturally differed in many aspects such as gender, age, nutritional, social, marital 
and general health status. These, and maybe other differences not measured, most 
probably affected the response to surgery and nutritional therapy.  
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Study A 
Our aim was to include 20-25 patients. However, because of the high tumour 
recurrence rate and a high mean age at diagnosis, the eligible number of patients 5 
years after surgery was very limited. Based on clinical experience that most 
patients do not recover their pre-illness weight it was decided to include 5 patients 
who did not fulfil the inclusion criteria of a weight loss >5% compared to 
preoperative weight. There was no inclusion criterion for BMI. This resulted in that 
4 of the 5 patients with a weight loss <5% also had a BMI close to (24.5) or more 
than 25. Two of these patients, although motivated in the beginning of the study, 
expressed later on a satisfaction with their weight. This underlines the importance 
of a thorough assessment to identify patients who most likely will benefit from 
nutritional therapy aiming to prevent loss of or to restore body mass. 
 
Study B 
This was a relatively large single centre study, in which ultimately 80 patients were 
operated and randomized. Due to the severity of the malignant disease more than 
30% of the patients were lost due to incurable or recurrent disease, or died. 14% 
declined further participation or were lost for follow up but only 4% failed to meet 
our inclusion criterion of repeated DXA measurements. Thus, our group of patients 
should be representative of patients surviving the first postoperative year after 
curatively intended upper gastrointestinal cancer surgery. 
 
The study included patients with different kinds of upper gastrointestinal disease 
which called for different kinds of resection procedures. As the oral nutritional 
therapy was symptom-based and since many of these patients do experience the 
same kind of symptoms we do not see this as a major issue.   
 
Study design 
One major drawback of these two studies is the absence of a control group. This 
renders it difficult to interpret the results since we do not know whether a change is 
due to nutritional therapy or other causes. Since the 80s oral nutritional therapy to 
this patient group is seen as a part of basic care at the hospital, and it would neither 
be feasible nor ethical appropriate to have “no nutrition” as the control.  
 
Both studies shared the same protocol for how often the patients met the dietitian. 
During the first six months follow-up was based on regular meetings. This offered 
the possibility to do a proper re-assessment of nutritional and general health status 
and monitor and evaluate the prescribed nutritional therapy.  
However, during the last 6 months of the studies patients and dietitian 
communicated over the telephone. The experience from study A was that the lack 
of a personal meeting hampered the monitoring of the nutritional therapy since not 
seeing the patient made it more difficult to reassess and adjust nutritional therapy to 
new circumstances. 
  
 62 
Dietary intake 
Energy intake was assessed by a 4D FR as the method was easy and not too time-
consuming. To reduce reporting error, much effort was put in careful instructions to 
the patients on how to record. After the recording period the dietitian and patients 
met and any ambiguities in the record could be clarified. However, there were large 
individual discrepancies between energy intake from 4D FR and TEE from DLW. 
Although measured at the same time period during the study, the length of the 
measurement period differed. DLW was a mean value of 14 days whereas 4D FR 
obviously was a mean of 4 days. A variation in energy intake of 20-30 % between 
different days has been reported [72]. In the present studies this variation can be 
even greater since a majority of patients after MUGI surgery suffer from eating-
related symptoms  [3] and there is a risk for a 4D FR to miss this variation.  
 
In study B we found that energy intake expressed as kcal/kg not at any time 
predicted changes in body weight. However, change in body weight was measured 
over a time period of at least one month so once again the discrepancy can be due 
to different time periods studied with regard to energy intake and body weight. 
 
Body composition 
DXA is a precise method to estimate body composition. Regional body 
composition is also estimated with adequate precision using DXA (although 
somewhat less than for total body composition). Coefficient of variation for BF was 
1.7%, for lean soft tissue 0.7%, and for appendicular lean soft tissue 2.7%. Body 
energy content was estimated with a coefficient variation of 1.02%. Thus, over a 
period of 6 months, the error of measurement was approximately 16 kcal per day, 
corresponding to ~1% of an average daily intake.  
 
Results in perspective 
Preoperative nutritional state, body composition and functional capacity  
Study B showed that 90% of the patients had a preoperative BMI >20. Since almost 
half of the patients had lost more then 10% of their pre-illness weight, BMI was not 
an indicator of nutritional deficit. Both BF and FFM were affected since our 
patients had significant lower levels as compared to a Swedish reference material 
[134].  
 
The most striking finding preoperatively was low appendicular skeletal muscle 
mass. This might have been caused either by preoperative weight loss, or by 
tumour induced stress metabolism, or by low physical activity. There has been a 
lack of Swedish data on reference values for muscle mass, however in 2009 
Tengvall et al [137] reported indices of TBSMM in 75-year old subjects. Still, to 
my knowledge the only existing DXA derived cut off values for sarcopenia is based 
on data from Baumgartner et al [135]. One third of our patients, mainly men, could 
be classified as sarcopenic according to these cut-off values. From the Baumgartner 
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study [135] the reported prevalences of sarcopenia in non-hispanic white men and 
women age <70 years were 14% and 23%, and in the age group 70-74, 20% and 
33% respectively. Compared to these data the prevalence of sarcopenia in our study 
was higher in men (48%) but lower in women (7%).  
 
Sarcopenia has been associated with functional impairment [135,138] and 
functional impairment has actually been included in a recent definition of 
sarcopenia [139]. Our patients had a reduced maximal exercise capacity compared 
to a middle-aged reference population measured on the same treadmill [136]. Also, 
patients classified with sarcopenia had a significantly lower exercise capacity 
compared to patients with normal appendicular muscle mass indices.  
 
Energy metabolism 
Measurements of TEE from DLW revealed a great spread. TEE ranged from 31-44 
kcal/kg. In accordance to this physical activity level varied within a wide range. 
This underlines the importance of individual assessment of energy requirements for 
patients receiving nutritional therapy and above all, a careful monitoring to evaluate 
the nutritional therapy and prescribed energy intake. 
 
Postoperative nutritional state and body composition 
The greatest postoperative weight loss occurred within the first month after surgery 
and persisted during the 12 months study. Six months after surgery more than 1/5 
of average body fat stores were lost, but there was no significant change in fat-free 
mass. Unfortunately, there was no measure of body composition after the first 
postoperative month so we do not know to what extent the different body 
compartments were affected. However, due to the surgical stress response 
metabolism losses of FFM can be expected adjacent to surgery and this has been 
verified in a few studies on body composition following MUGI surgery [140-142].  
 
Perhaps the most striking finding was the heterogeneity in weight development 
after surgery. Almost one third of the patients remained weight stable with even a 
gain in FFM 12 months after surgery. This was opposed to the weight losing group 
who lost some FFM, but almost 90% of the lost body mass was BF. This indicates 
an energy balance problem due to a reduced intake rather than a prolonged 
catabolic effect.  
 
We found no preoperative variables that could explain this difference in 
postoperative recovery except that weight stable patients reported a higher 
preoperative weight loss. This is consistent with the finding of Martin et al [143] 
where an increased preoperative weight loss was associated with a decreased risk of 
weight loss after oesophageal and cardia cancer surgery. Martin et al suggested that 
patients with a greater preoperative weight loss received more nutritional attention 
after surgery. However, in our study all patients received individualized dietary 
counselling prescribed by a dietitian, which makes this explanation less likely in 
 64 
our patients. Also, we could not relate preoperative nutritional status as assessed by 
BMI to postoperative weight development. 
 
From the extended analysis in study A it seems likely that patients classified as 
weight stable during the first postoperative year still had higher FFMI, appendicular 
skeletal muscle mass index and functional capacity long time after surgery. 
Although patients in study A are too few to draw any conclusions, it is an 
interesting observation that could be subject to further studies. We can only 
speculate that weight stable patients do better in the long run but the reasons why 
some patients lose weight while others don’t remain to be explored.   
 
Contrary to our anticipations nutritional therapy long time after surgery did not 
change body weight or body composition. However, also in this group of patients 
effects on body weight and body composition were heterogeneous. About half of 
the patients increased their body weight during the intervention year, and BF 
accounted for this gain in body mass. The other half of patients remained weight 
stable and co-morbidity had a great impact on weight development.   
 
Skeletal muscle mass and functional capacity 
Although TBSMM was regained at 12 months there was no further recovery of the 
preoperative low muscle mass. Long time after TG two thirds of the patients in 
study A were classified as sarcopenic [135] indicating a further muscle mass loss 
over time.  
 
Change in TBSMM was related to change in body weight but analyzed by 
subgroups this was only significant in men but not in women, weight losing and 
weight stable. Maybe, men and women respond differently in degree of muscle 
mass changes in relation to how weight changes. However, these results must be 
interpreted cautiously as there were few women, and also small changes in 
TBSMM. The lack of relationship in the weight losing and weight stable groups 
could possibly be explained by the fact that both men and women were represented 
in each group. 
 
We found a clear relationship between TBSMM and functional capacity measured 
as exercise capacity. We also found a relationship between changes in exercise 
capacity and changes in TBSMM. This indicates that development of TBSMM has 
a major impact on functional capacity.  
 
Energy balance 
The magnitude of the average energy deficit as measured from differences in body 
energy content might be overcome by oral intake. Worth mentioning is that we 
have measured gross energy balance, which can not be directly translated to energy 
intake. Factors of importance are 1) changes in body mass (weight) affect energy 
requirements, 2) approximately 5% of food energy is normally not absorbed, also 
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some of these patients has an additional malabsorption caused by surgery, 3) to 
what extent extra energy intake is stored as body mass depends on how much of the 
extra energy is used as physical activity energy. This means that the energy intake 
to overcome the calculated energy deficit based on change in body energy content 
must be somewhat higher. In addition, all of these patients already received 
nutritional therapy to optimise energy intake. To further increase energy intake, 
nutritional therapy strategies probably must be reconsidered. 
 
We could not find a linear relationship between energy balance and exercise 
capacity. However, the weight losing group had a significantly higher proportion of 
patients who reduced their exercise capacity compared to the weight stable group. 
This much more complex relationship requires additional studies.  
 
Physical activity and physical activity energy 
Both ActiReg® and HPAQmodified were found to underestimate TEE compared to 
DLW. The underestimation was seen at higher physical activity levels while on 
lower levels, especially ActiReg®, gave an impressively accurate measure of energy 
expenditure.  
This is supported by other validation studies of ActiReg®. In the study of Hustvedt 
-who developed the equipment- et al [125] in a group of young female students, 
ActiReg® was found to give an accurate measure of TEE on group level although 
with a standard deviation of 320 kcal/day. On higher levels of energy expenditure 
(>2600 kcal/day), ActiReg® underestimated to a greater extent. The female students 
reached a PAL of 1.71. In the study of Arvidsson et al [144] in a group of non-
hospitalized patients, suffering from severe chronic obstructive pulmonary disease, 
ActiReg® gave a valid estimate of TEE from ActiReg®, with a standard deviation of 
190 kcal/day. However, PAL in this group was only 1.51. Based on these results it 
can be concluded that the ActiReg®-system is well adapted to assess TEE at lower 
levels of physical activity whereas at higher levels there is a great spread in 
individual difference between ActiReg® and DLW.  
 
As opposed to HPAQmodified , ActiReg® showed a variation comparable to DLW in 
estimation of TEE changes over time. This is a very interesting finding since this 
measure might be used to assess functional outcome after nutritional intervention. 
However, this requires further studies since TEE did not change in our study. 
 
Up to date no validation study of motion sensors has proven a high enough 
precision in the estimate of total energy expenditure/physical activity energy 
expenditure at the individual level [54,145]. If nutritional therapy results in a more 
ambulatory patient, a more patient-centred outcome measure might be the ability of 
ActiReg® to estimate time spent in different body positions and activity levels.  
 
The physical activity interview was difficult to perform and relied heavily on the 
patients’ memory. In relation to the workload and the difficulties with the 
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interviews, the clinical usefulness of this method seems limited. Other validation 
studies of physical activity questionnaires against DLW show generally low 
correlations with both under- and overestimates or agreement at the group level but 
with considerable error on the individual level [124].  
 
Oral nutritional therapy 
In study A we used the 4D FR to evaluate and re-assess oral nutritional therapy. 
Based on food choices and meal pattern it seemed as they followed previously 
prescribed diet recommendations. Energy density of the diet is primarily affected 
by the fat and water content. The reported energy density of 0.97 kcal/g seems to be 
somewhat higher compared to the findings of other studies [146,147] which also 
support the view that they still ate a diet high in fat. However, many patients had 
problem to increase their food intake due to symptoms commonly seen in 
gastrectomized patients, and thereby to reach their energy needs to achieve a 
weight gain. Therefore, a majority of the patients were prescribed ONS. 
 
However, energy intake and number of eating occasions were unchanged at the end 
of the study. This implies that ONS suppressed ordinary food intake since reported 
compliance to prescription of ONS was good. It has earlier been recognized that 
long term use of ONS can led to suppression of food intake [1]. It could also be the 
case that under some circumstances e.g. illness, some of these patients found it 
easier and more convenient to use ONS than to prepare a meal. We do not know, 
but if this is the case ONS still fulfilled its purpose to increase energy and nutrient 
intake.  
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SUMMARY OF STUDY RESULTS 
 
In this thesis the focus has been on the short and long-term effects on energy 
balance, body composition and functional capacity in patients on oral nutritional 
therapy after major upper gastrointestinal surgery.  
 
The main findings are summarized as follows: 
 
Preoperative nutritional status shows a BMI within the normal range for the 
majority of patients and this is also found long time after surgery. However, BMI, 
BFI and FFMI were low compared to a Swedish reference population. Almost half 
of the patients lost >10% of their body weight and one third were classified as 
sarcopenic.  
 
The greatest weight loss after major upper gastrointestinal surgery occurred within 
the first postoperative month and then persisted during the subsequent year. This 
weight loss is not regained even long time after surgery, since in the group of TG 
patients, there was still a weight loss of 6% compared to preoperative weight on 
average 10 years postoperatively.  
 
Nearly 90% of the lost body mass during the first postoperative year consisted of 
body fat whereas fat free mass was not significantly changed. Total body skeletal 
muscle mass was reduced 6 months after surgery, but was regained at 12 months. 
Total body skeletal muscle mass most probably do not ever reach normal values 
since two thirds of the patients in study A were sarcopenic on average 10 years 
after surgery.  
 
There was a great heterogeneity in weight development. One year after surgery two 
thirds of the patients had lost weight and one third remained weight stable. In the 
weight losing group both body fat and fat-free mass were significantly reduced and 
in the weight stable group there was no significant change in body fat but a gain in 
fat-free mass. Neither BMI, REE, energy intake nor length of artificial nutrition 
support could explain these differences in weight development. However, the 
weight stable group reported a higher preoperative weight loss. 
 
Although oral nutritional therapy did not change body weight, body composition or 
energy metabolism in the group of patients long time after total gastrectomy, the 
responses were quite heterogeneous. About half of the patients responded with 
weight gain while in the other half weight was either lost or did not change. Co-
morbidity appeared to have a negative effect on body weight development while a 
satisfaction with body weight was expressed when BMI >25 and weight loss 
(compared to pre-illness weight and) since the time of surgery was less than 5%. 
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Measures of TEE by DLW showed a great variation in physical activity levels. 
Although both ActiReg® and HPAQmodified were correlated with TEE from DLW 
there was an underestimation of TEE. Underestimation was particularly detected at 
higher levels of physical activities. ActiReg® showed a high validity to measure 
change in TEE over time as opposed HPAQmodified. However, results need to be 
confirmed in further studies since there was no average change in TEE in this 
study. 
 
 
 69
CONCLUSIONS AND FUTURE PERSPECTIVES 
 
 
Our results highlight the need for a standardized NCP in which a meticulous 
assessment of the individual patient is undertaken aimed to decide on proper 
nutrition diagnose and adequate nutritional therapy, further for evaluation of 
individual goals that should be achieved by the prescribed nutritional therapy.  
 
We found that BMI on its own was not a good predictor of nutritional status in our 
patients, both before and after major upper gastrointestinal surgery. A BMI within 
normal range can have been preceded by a major weight loss. Also a BMI within 
normal range can coexist with a reduced muscle mass which we found was directly 
related to functional capacity. There was also a wide range in physical activity 
levels and thus a wide range in energy requirements. Heterogeneity in weight 
development also stresses the importance of a careful assessment/reassessment of 
patients to allocate most resources to those most in need. 
 
Monitoring and reassessment of oral nutritional therapy was hampered by not 
directly meeting the patients during the last six months of the study. The frequency 
of dietary counselling and also the balance between direct meetings and telephone 
contacts must be thoroughly considered. 
 
Development of methodology 
Registration of food intake and appetite 
The large day-to-day variation in patients’ food intake, from good days, when 
dietary intake is adequate, to bad days, when the intake may be almost non-existent, 
makes the traditional registration of dietary food intake by a 4D FR unsatisfactory. 
The method only records a few days compared to, as in this case, a one year long 
intervention. To obtain a more representative measure of food intake during the 
period of study, different methods can be discussed.  
 
Retrospective methods are intended to reflect past food intake of varying length. 
However, the intention of these methods is to capture habitual food intake and 
fluctuations in food intake is probably impossible to detect. Retrospective methods 
are dependent on the memory of the recipient and the fluctuation in food intake due 
to good and bad days is probably more difficult to assess by these methods.  
 
If the goal is to understand the pattern of appetite and eating behaviour and how 
this interacts with weight development, maybe a different approach should be 
evaluated. To be able to follow changes in food intake during a longer period an 
everyday simple notation of estimated intake during the day could be of more value 
and better capture the variation in food intake instead of trying to assess the 
absolute amount of energy and nutrients. Further, there is a need for development 
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of scales for rating appetite to mirror how self perceived appetite varies and 
develops. 
 
Development of oral nutritional therapy 
There is a great need to develop methods that makes it possible to objectively 
evaluate nutritional therapy. The general lack of method descriptions or definitions 
of oral nutritional therapy is an obstacle. “Dietary counselling” and “dietary 
advice” are often used interchangeable, without descriptions or definitions. This 
complicates and precludes evaluation and interpretation of result, comparison of 
results between studies and the possibility to repeat studies. 
 
There is no structure for how central concepts and terms in the field of nutrition 
therapy are oriented to each other and there is no consensus on definition of the 
terms used. This complicates the process of describing and evaluating nutritional 
therapy. During the time it took to complete this thesis, I made a journey towards a 
more conscious way to use expressions and terms. One example is how the concept 
of oral nutritional support was used. From the beginning, I used it as a generic term 
for “the whole package” that a dietitian can offer but without a definition. Now it 
has been replaced by oral nutritional therapy which is the overarching concept of 
diet therapy and supplements (fig 2, page 20). Using a standardized nutrition 
language and a common approach and framework for nutritional therapy gives us 
the opportunity to do “good research” and move from experienced-based to 
evidence-based practice. 
 
Body composition 
The low FFMI before surgery and also the high frequency of sarcopenia both 
before but also long time surgery calls for the use of simple methods to identify 
these patients. Low FFMI is associated with longer hospital stay and sarcopenia is 
associated with functional impairment and disability. Easily applied methods for 
determination of skeletal muscle mass, like bioimpedance analysis, could be of 
potential clinical value for evaluation of the development of sarcopenia in these 
patients. This, however, requires further validation.  
 
Interventions to restore and regain body mass and muscle mass 
There is exciting new research indicating that eicosapentaenoic acid (EPA) might 
have immunomodulatory or moderating effects on inflammation, thereby reducing 
the degradation of lean body mass in patients after oesophageal cancer surgery 
[140].  
 
The concept of ERAS (enhanced recovery after surgery) has been applied to 
colorectal surgery with success. However, due to nausea, delayed gastric emptying 
and the frequently used “nil-by-mouth” strategy the introduction of ERAS has been 
hampered in major upper gastrointestinal surgery. However, as shown by Suehiro 
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et al, Lassen et al and Hur et al [114-116] no differences in morbidity were found 
instead it seems like “food-at-will” has several advantages.  
 
Evidence from exercise intervention studies in cancer patients also shows 
preliminary positive physiological and psychological benefits from exercise, 
including preservation or increase in muscle mass, when undertaken during or after 
traditional cancer treatment [148]. However, the optimal exercise prescription 
remains so far unknown and may depend on cancer type, treatment modality and 
patient characteristics. 
 
Finally, to optimize the effects on skeletal muscle mass of physical therapy the 
distribution and amount of protein intake can be considered. A recent review [149] 
recommends a consumption of 25-30 g high quality protein for each of three daily 
meals (1.0-1.2 g protein per kg and day) and to incorporate habitual exercise in 
close temporal proximity to these meals.  
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